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Preface 
Biomedical applications of polymer-composite materials have experienced an 
ascending trend during the last few decades. A composite is a material constituted by at 
least two separate phases (the matrix and the reinforcement) with different physical and 
chemical properties that result to a new material with a significant different properties 
compare to those of reference materials. Biopolymers-calcium phosphate is one of the 
most frequently used composite system in biomedical applications especially in the 
regeneration of hard tissue and drug delivery. Incorporation of inorganic materials like 
calcium phosphate into polymer matrix, or reverse, may enhance biocompatibility, 
mechanical properties and modified swelling and drug release behavior of individual 
components. Another significant factors which need to be taken into consideration are the 
type and content of reinforcement component to tailor these properties to specific 
demands. 
Alginate is a promising polysaccharide polymer which has been extensively used 
owing to its biocompatibility low toxicity and mild gelation conditions. Alginate have 
been subjected to the incorporation with calcium phosphate materials specially 
hydroxyapatite for drug delivery application. This secondary phase not only improved 
mechanical properties such as compressive strength and toughness, but also it resulted to 
a sustained release profile. Recently dicalcium phosphates including brushite and 
 x 
monetite have risen the attentions due to their superior biodegradability in physiological 
conditions respect to other calcium phosphates. 
My PhD was oriented toward developing drug delivery system based on Alginate 
and brushite. Therefore, in the first chapter a brief information about alginate and 
brushite was provided. In addition, this chapter include a quick overview over different 
biomedical applications of these materials. This chapter was followed by three chapters 
which have their own introduction, materials and method, results and discussion, and 
conclusion.  
In the second chapter, the process of in-situ formation of Alginate-brushite 
composite hydrogels for their prospective usage as drug delivery systems was 
investigated. This composite hydrogel could be of particular interest in oral drug delivery 
systems and hard tissue regeneration especially in dental and periodontal local treatment. 
The effect of initial pH and phosphate concentration on the in-situ formation of brushite 
inside the Alginate matrix were taken into account. The different samples were 
characterized by XRD, FTIR, SEM, TGA, DTA, and MTT 
Evaluation of in-situ synthetized Alginate-Brushite hydrogel composites as a 
novel pH sensitive drug carriers was discussed in the third chapter. The different carrier 
formulations as well as the final composites have been fully characterized to understand 
the carriers-drug interactions. The mechanical properties and the swelling behaviors were 
evaluated with respect to changes in the content of raw materials to thoroughly 
investigate the mechanical property impacts on the release behavior of these composite 
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materials. Sodium salt of Ibuprofen (Ibu) was used as a model drug to perform release 
experiments. 
The aim of fourth chapter was fabricating a functionalized bone cement substitute 
for the local delivery of Gentamicin sulfate. The effects of alginate concentration on 
microstructural, mechanical, and biological properties of brushite cement as a Gentamicin 
sulfate carrier was studied in the first part of this chapter. In the second part, the most 
adequate concentration of alginate according the obtained results in the first part was 
chosen to load Gentamicin with different concentrations through liquid phase or solid 
phase. Finally, different formulations of cement were examined in terms of setting time, 
chemical composition, and chemical, morphological and mechanical changes in response 
to soaking in PBS along with evaluation of Gentamicin release by these cements for a 
period of two weeks.   
  Finally, highlights of different part of my projects was reported as the final 
chapter entitled conclusion. It is noteworthy that the major part of this thesis has already 
been published in the form of research articles in international peer reviewed journals. 
Since all of those works were carried out by me under supervision of my tutor, I have 
freely used text, figures and tables in those publications.  
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CHAPTER 1 
Introduction 
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In conventional drug administration methods, most drugs fail to achieve favorable 
clinical outcomes, because of the very fast release rate and the difficulty, represented by 
biological barriers, for the drug to reach its intended target. Therefore, these methods 
entail the administration of high drug dosages and a significant amount of these is ‘lost’ 
over healthy tissues and organs, with the risk of provoking severe side effects.   
The idea of developing a DDS1 that selectively kills unhealthy cells, while leaving 
healthy ones untouched, was first introduced by Paul Ehrlich over a century ago. Since 
then, the development of systems for the targeted delivery of drugs directly at the desired 
site of action and with a controlled release rate has been the object of several studies. 
Controlled drug delivery systems would offer significant advantages when compared to 
conventional methods, including higher therapeutic efficiency, lower toxicity and better 
patient compliance. This chapter is a quick overview over the Alg2 and Bru3 materials 
which have been used to develop DDS 
1.1 Alginate 
Alg is a conventional polysaccharide obtained from brown algae such as kelp. Alg 
is able to form hydrogel at mild pH and entrapping drugs, biomolecules, and cells. 
                                                 
1 Drug Delivery Systems 
2 Alginate 
3 Brushite 
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Biocompatibility, low toxicity, and low price of Alg have made it a proper material to 
investigate and use for numerous biomedical applications [1]. 
1.1.1 Chemical structure  
Alg was first discovered by Edward Stanford, a Scottish chemist, in 1883, but it 
was only with the work of Fischer and Dörfel in the 1950s that its structure became fully 
known. Alg is an anionic biopolymer composed of α-L-guluronicacid (G) and the β-D-
mannuronic acid (M) (Figure. 1) which glycosidic bonds link guluronicacid (G) and 
mannuronic acid (β-(1–4) and α-(1–4)) together. Although there is a possibility to obtain 
Alg from bacterial sources, commercially available Alg is only extracted from algal 
sources. Different characteristic such as copolymer sequence and molecular weight are 
totally depending on the source of copolymers [2]. 
  
  
 
Figure 1. Chemical structure of mannuronate and guluronate, the ‘building blocks’ of Alg [2]. 
4 
 
Consecutive guluronic residues (GGG), mannuronic residues (MMM) and blocks 
made of random or alternating residues (MGM) as shown by Figure. 2 are three types of 
block which form Alg structure. Alg structural properties is influenced by the type of 
blocks. In addition, properties like solubility and hydrophobicity in Alg derivatives can 
be modified through controlling the monosaccharide sequence and nature, location and 
quantity of substituents, as well [1]. For instance, chains made by the alternating MG 
units are more flexible and soluble at lower pH than the other kinds, while G-blocks give 
stiffer chains. Thus, the distribution and proportion of the two residues in the structure are 
critical factors affecting the chemical and physical properties of Alg.  Noteworthy that the 
relative amount of guluronate and mannuronate may significantly vary in different Alg 
depending on the source extraction [3]. 
 
 
 
  
Figure 2. Structure of G-blocks, M-blocks and alternating blocks in Alg 
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Ionically cross-linked Alg hydrogels are obtained in the presence of divalent 
cations, such as Ca2+. It has been reported that structure of Alg and type of cations are 
dominant parameter in bonding strength. For instance, Alg with high content of G-blocks 
form stronger gels than the high-M or high-MG due to the fact that bonding with G 
blocks is more favorable for divalent. Besides, it has been reported that the boning 
strength has descending trend within the following order of divalent:  Pb > Cu > Cd > Ba 
> Sr > Ca >Co, Ni, and Zn > Mn [2, 4, 5]. Figure. 3 shows three possible types of 
junction in Ca-Alg hydrogels. 
 
Figure 3. a) GG/GG b) MG/MG and c) GG/MG junction points in Alg [6] 
1.1.2 Physical properties 
Physical properties of Alg and its hydrogels intensively depend on structural 
factors such as sequence of M and G block, length of G blocks, and molecular weight. 
Moreover, these factors have a direct impact on the mechanical properties of Alg 
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hydrogels as well as their stability so that increase in the length of G blocks and 
molecular weight will result in mechanical properties and stability enhancement [3].  
Also, there is a direct relationship between the viscosity of Alg solution and 
molecular weight of Alg so that Alg with higher molecular weight will yield to more 
viscose solution. However, sever viscose solutions are not desirable due to the hard 
processing of that. In addition, the pH of solution is another significant factor which has 
an important role in the viscosity of Alg. Protonation of carboxylate group in the Alg 
backbone as pH decrees will cause an increase in the viscosity. Furthermore, pH of 
solvent, ionic strength of the medium, and presence of gelling ions determined Alg 
solubility in water. It has been suggested that pH of solution should be above pKa of Alg 
to deprotonate the carboxyl acid group of Alg and subsequently increase water solubility. 
Noteworthy that physical properties of Alg and its gels can be modified by selecting 
primary compound structure (high-G, high-M, and poly MG) and gelling agents [7-9].    
1.1.3 Hydrogel formation: the ‘egg-box’ model  
The most common method to form Alg hydrogel is chelating with divalent cations 
such as Ca, Sr, and Mn through an ionic bonding. The Gel is obtained through 
participation of G blocks to form a tight held junction. This is due to the fact that G 
blocks structure is able to highly coordinate with divalent cations. Therefore, at least two 
polymeric chain will be aliened so that G blocks of one will form the junction with the 
adjacent G block through entrapping cations [4]. Also, this is associated with weak 
junction arising from participation of MG blocks [6]. This gelling mechanism was first 
described in 1973 and called as ‘egg-box’ model owing to its appearance [10]. As be seen 
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in Figure. 4, four G blocks (two from one polymeric chain) are surrounding divalent 
cations to form the junction. Among all the divalent cations, Ca is the most frequently 
used in formation of hydrogels. However, the stability of Ca-Alg in physiological 
conditions is poor because of fast integration resulting from ion exchange reaction with 
monovalent cations [1]. 
   
 
Figure 4. Ionotropic gelation of Alg according to the egg-box model 
 
1.1.4  Biomedical applications  
Alg have been widely used in biomedical applications ranging from tissue 
engineering to wound dressing and cell culturing.  
 Wound dressing 
The traditional wound dressing materials act as a barrier to prevent bleeding and 
maintain the wound area dry by evaporating wound exudate and hindering 
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pathogens inclusion to the wound area. The next generation of wound dressings 
like, Alg dressing, contain moisture to assist wound healing process [11]. Alg 
freeze-dried sheets and nonwoven fibers are extensively using in this regard, since 
they adsorb wound area blood and regel. Therefore, they can provide the desire 
physiological moisture to the wound area and decline the risk of bacterial infection 
at there. Subsequently, enhance in formation of granulated tissue, epithelialization 
rate which facilitate healing are listed as the result of using Alg wound dressing. 
Noteworthy that various kind of Alg wound dressing are commercially available. 
Further investigation yielded to fabrication of bioactive Alg wound dressing 
through incorporation of therapeutic agents such as dibutyryl cyclic adenosine 
monophosphate, stromal cell-derived factor-1, silver nanoparticle, and zinc ions. 
Completing re-epithelization, accelerating wound closure, minimizing scar 
formation, increasing antimicrobial activity and antioxidant capacity, promoting 
keratinocyte migration, and enhancing the level of endogenous growth factors at 
the wound microenvironment are listed as the advantageous of these kind of Alg 
wound dressing over the previous ones  [12-15].  
 Cell culture  
Another significant application of Alg hydrogels are fabricating scaffold for 
culturing cells and being used as ideal blank slate. This is derived from poor protein 
adsorption capacity of Alg along with the lack of mammalian cell receptors for Alg. In 
this regard, Alg hydrogels are being used as 2D or 3D culture system for specific cell 
adhering demands through coupling synthetic peptides. Moreover, biocompatibility as 
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well as simplicity of Alg to be introduced into body have made the result obtained in in-
vitro condition extensible to in-vivo conditions. One remarkable example is entrapping 
neural cells stem cells in 3D Alg platform in in-vitro conditions to evaluate impact of Alg 
hydrogel and mechanical properties on the neural cells differentiation and proliferation. 
The results confirmed the positive effect of Alg 3D scaffold on promoting differentiation, 
growth and extension of neurite [3]. 
 Drug delivery  
The main role of Alg in delivering pharmaceutical agents are stabilizing and 
hindering it to have a controlled release. Alg hydrogels have been extensively used as 
drug carriers in oral uptake form. In addition, usage of Alg hydrogels as local delivery 
carriers have gain attentions. It has been stated that Alg hydrogels have nonoporous 
structure (pore size ∼ 5 nm) [16] which let the drug molecules, especially low molecular 
weight drug, diffuse to the surrounding media. Therefore, drug diffusion is the primary 
mechanism for the drug release followed by gel gradual disintegration. Besides, water 
solubility of the drug plays an important role in determination of release mechanism so 
that drug diffusion and gel degradation are dominant mechanism for water soluble and 
non-soluble drugs, respectively. The content of Alg influences the size of pore which is 
significant factor for the diffusion of the drug. In general, the pore size increases parallel 
with increase in Alg content which facilitate migration of water inside the matrix and 
faster release. Furthermore, the pores are affected by the chemical structure of Alg so that 
high G Alg possess higher open pores than high M ones and yield to superior drug 
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diffusion rate. Nonetheless, burst release associated with Alg hydrogels is not ignorable 
[17]. 
The interactions between drug and Alg matrix effects on the release kinetic, as 
well. Drugs that stablish primary or secondary bonding (combination of ionic and 
covalent cross-linking) with Alg will cause restricting swelling of Alg which 
subsequently prolong the release profile. Another approach is entrapping several drug 
into Alg based hydrogels for simultaneous or sequential delivery and altering releasing 
each drug through chemical and structural changes. For instance, co delivery of 
methotrexate and doxorubicin is carrying out through fast diffusion for methotrexate (no 
interaction with Alg and chemical hydrolysis of cross-linker for doxorubicin (covalently 
bonded to Alg), respectively [18, 19]. Also, prolonging release profile through 
combination of Alg with poly cationic polymers has been extensively studied for smart 
delivery demands. Electrostatic adsorption in certain pH range restricts swelling behavior 
in off-state of release followed by electrostatic repulsion in on-state of release which 
facilitate swelling of the carrier defines as the release mechanism [20]. Moreover, Alg 
derived hydrogels have high potential for protein delivery owing to the fact that proteins 
can be entrapped into the hydrogels through a relatively mild conditions and Alg gel 
prevent degradation of protein till release them. This application of Alg assists tissue 
engineering for regeneration of bones, blood vessels, and muscles. Yet, fast release of 
protein from intrinsic pores of Alg as well as hydrophilic nature of the network is listed 
as the limitation of Alg as carrier of proteins [3].   
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 Tissue engineering 
Alg hydrogels capability in cell and protein delivery along with Alg cell adhesion 
properties and degradable nature have made it a suitable materials for tissue engineering 
and regeneration of various organs. However, the pore size of Alg hydrogel is the main 
barrier for the releasing regenerative agents from Alg. It has been reported that most 
protein are able to release from Alg through diffusion mechanism and degradation of Alg 
would accelerate the release [21]. It should be noted that large molecules such as DNA 
and antibodies are released by degradation of Alg gels [22, 23]. The most frequently used 
tissue engineering application of Alg is explained bellow: 
a) Blood vessels  
Neovascularization which is referred to new blood vessel formation is a novel 
treatment for those patient suffering from blood flow obstruction and restriction. 
Transplantation of different cell types such as angiogenic molecules, heparin binding 
growth factors into the patient body help neovascularization. The local delivery of these 
therapeutic agents can be achieved via carrying them by Alg hydrogels [24-27]. It has 
been shown that direct injection of Alg gel loaded with VEGF4 into ischemic muscle 
tissue yielded to a long term release of VEGF in the ischemic area and assisted formation 
of new capillary[28]. Also, sequential delivery of growth factor from Alg gels for 
different stages of treatment has been investigated to enhance maturation of new tissue 
                                                 
4 vascular endothelial growth factor 
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and functionality. In vivo results on mice showed that sequentional delivery of VEGF and 
PDGF-BB5, two growth factor, by Alg resulted in promoting blood vessels formation and 
maturation [29, 30]. Further investigations were carried out on the co-delivery of VEGF, 
MCP-16 and endothelial cells from Alg gels improved blood vessels formation [31, 32]. 
b) Bone tissue engineering 
The main role of Alg in bone tissue engineering is delivering osteoinductive 
factors and bone forming cells. The main merits of Alg usage are minimally invasive 
introduction, filling irregular damaged area, simple chemical modifications, and 
controlled releasing of osteoinduction agents. What we should take into condiseration is 
that Alg gels are not suitable for load bearing tissue without fixation due to the fact that 
they possess weak mechanical properties. Alg gels have successfully used in bone growth 
factor delivery in animal model which directly impacted on bone regeneration [33]. In 
addition, sequential delivery of BMPs7 (BMP-2 and BMP-7) as well as co-delivery of 
BMP-2 and VEGF resulted by Alg gels assisted bone marrow stem cell differentiation 
and improved new bone tissue formation [34-37]. Another approach is incorporating Alg 
with bioactive materials such as HA8 to promote bone formation. In this approach 
                                                 
5 platelet-derived growth factor-BB 
6 Monocyte chemotactic protein-1  
7 Bone morphogenetic proteins 
8 Hydroxyapatite 
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osteosarcoma cells are capable of adhering to the surface of scaffold and proliferate 
through interconnected pores of it which is useful for load bearing demands [38, 39]. 
Bone marrow stromal cells attachment and proliferation can be further improved by 
combining Alg with collagen type 1 and β-TCP [40]. 
c) Cartilage repair 
One of the most challenging area of tissue engineering is cartilage repair owing to lack of 
proper concentration of chondrocyte and blood supply in the damaged area. In addition, 
poor mechanical properties of the damaged cartilage limits in-situ treatment of the 
damaged area by. One decent solution is fabricating mechanically stable cartilage in ex-
vivo conditions followed by implanting in the damaged site. Alg gels have shown a 
promising potential for delivering chondrogenic cells in in-vivo conditions to repair 
damaged cartilage. The primary attempts was carried out by suspending chondrocyte in a 
solution containing Alg and calcium sulfate followed by molding and shaping cartilage 
implant [41, 42]. Application of stem cell to restore cartilage functionality has drawn 
attentions. It has been reported that using Alg modulate stem cell differentiation which 
resulted in chondrogenesis improvement. In addition, cell morphology regulation of 
chondrogeninc stem cells toward favorable round shape is facilitated in presence of Alg 
gels [43-45]. 
1.2 Brushite 
Bru is a kind of calcium phosphate materials which have been widely used as 
bone cement owing to its osteocunductive properties and superior biodegradability 
respect to other calcium phosphate materials. It was discovered by Mirtchi and Lemaître 
14 
 
in 1989 . Generally, it is synthetized through an exothermic reaction between acidic and 
basic calcium phosphate sources. It has been reported that Bru is biocompatible and 
metastable under physiological conditions. However, fast setting and pour mechanical 
properties is listed as the main drawbacks of Bru materials [46].  
1.2.1 Composition 
Bru is constituting from a basic calcium source, an acidic phosphate source, 
water, and additive for prolonging setting time or enhancing mechanical properties. 
 Basic calcium sources 
Since Bru has the calcium to phosphate ratio of one, the main calcium source is 
other calcium phosphate materials which have high Ca/P ratio such as TTCP9 [47]. The 
most frequently used calcium phosphate as calcium source is β-TCP10 which have low 
energy requirement in this regard. Calcium oxide and calcium hydroxide have been used 
as calcium source, as well [48].  
 Acidic phosphate source 
MCPM11 is the only calcium phosphate which can be used as phosphate source 
due to the fact that its Ca/P ratio is lower than one. In addition, MCPM donates one of its 
                                                 
9 tetracalcium phosphate 
10 β-Tricalcium phosphate  
11 Monocalcium phosphate monohydrate  
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structural water and facilitate precipitation of Bru. Another phosphate source is 
phosphoric acid [48, 49].  
 Additive 
In order to tune the properties of Bru cements for a specific demand, additive 
incorporate into fabrication process. Some compounds such as pyrophosphate, sulfates, 
carbohydrates and carboxylic acid have been added to raw materials to prolong the 
setting reaction [50]. Also, hydrophilic polymers particularly hydrogels such as silica gel 
[51], hyaluronic acid [52], and albumin [53] are added at low concentration to improve 
injectability and cohesion of Bru cement. On the other hand, polymers such collagen type 
1 and poly (lactic acid–co-glycolic acid) improve mechanical performance of the cement 
[48]. Moreover, incorporation of ionic metals such as Mg [54] and Sr [55] through 
metallic salt or doping cement precursors is another kind of additive which hinder setting 
time and modify final properties .  
1.2.2 Setting reaction 
Four phenomena are occurred within the setting reaction including dissolution of 
precursor in a solvent, formation of super-saturated gel, nucleation and growth inside the 
gel, formation of a solid of interlocked crystals. For example, the following equations 
will occurs to form Bru, if MCPM/β-TCP use as cement powder constituents [48]: 
I. Ca(H2PO4)2.H2O                                                                  Ca2+ + 2H2PO4- +H2O 
II. β-Ca3(PO4)2 + 4H+                                                              3Ca2+ + 2H2PO4- 
III. Ca2+ +H2PO4- + 2H2O                                                         CaHPO4.2H2O + H+ 
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IV. Ca(H2PO4)2.H2O + β-Ca3(PO4)2                                          4CaHPO4.2H2O     
1.2.3 Biomedical applications 
Orthopedics and dental applications are the main area of Bru usage which 
successfully passed in-vitro and in-vivo examination and are clinically available. In 
addition, this material is involved in area of biotechnology such as cancer therapy, drug 
delivery, and biosensors development. A brief overview about biomedical application of 
this materials is discussed in the following part of introduction chapter. 
 Orthopedics 
The main area of Bru applications in orthopedic fields relate to Restoration of 
metaphyseal defects, ligament anchor, reinforcement of osteosynthesis screws, and 
vertebroplasty. One of the most challenging area for orthopedics is in proximity of joints 
particularly in old people where typical treatment are associated with side effects [56]. 
Injectable Bru cement have successfully been used to treat defects in proximity of joint 
such as tibial plateau distal radial with high success rate. Although leakage of Bru cement 
to the adjacent tissue was observed, the cement finally adsorbed without showing 
siginificant side effect [56, 57]. Also, it has been showed that 3D printed Bru cement are 
capable of anchoring ligament to bone with a proper mechanical interface [58, 59].  One 
crucial factor in treatment of complicated bone defects is stability of osteosynthesis 
screws especially in the case of patient suffering from osteoporosis. Previously PMMA12 
                                                 
12 poly(methyl methacrylate) 
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bone cement was used to stabilize these screws, but undeniable side effects such as 
exotermic setting reaction, non-degradability, and cytotoxic monomer have limited the 
usage of PMMA. Biodegradable Bru is a promising candidate to fix the screw, as it 
increases the pull-out force by 3-folds [60]. Finally, injectable Bru has shown a good 
capability to fill and fix damaged osteoporotic vertebrae. The results indicated that Bru 
improved mineral density of osteoporotic vertebrae by up to 20–50 % yielded to improve 
stiffness and maximum force before failure [61]. 
 Craniofacial surgery 
Bru is a possible candidate for treatment of craniotomy defects, as it was observed 
in animal models that it induced osteogeneration and formation of fibrous tissue [62]. 
Preventing temporal depression in parietal craniotomies after craniotomy is another 
application of Bru in this area with superior outcomes respect to simple repair [63]. 
Custom made 3D printed craniofacial implant of Bru ceramic have been testing in tested 
for bone defects in cadavers. However, there is no record of clinical usage [64]. Vertical 
bone augmentation and bone defect healing are significant applications of Bru in 
maxillofacial surgeries. In this regard, Bru is using in the form of injectable cement or 
ceramic granules [65, 66]. Bru cement is injecting under the periosteum and set on the 
bone surface which will support bone growth in vertical direction [65]. Bru granules has 
the same impact on the vertical bone augmentation and the results was more promising 
respect to commercial bovine HA [67]. 
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 Drug delivery 
Bru cement has a good potential to act as a carrier of therapeutic agents such as 
drug, bioactive molecules and cells owing to its intrinsic porosity. The setting of Bru 
cement takes place at room or body temperature which prevent thermal denaturalization 
and activity loss during fabrication and implantation. These factors help Bru to have dual 
applications of osteoconductive bone grafts and local DDS. Method of drug loading is a 
very important factor which have a significant influence on the drug distribution and 
interactions with Bru. Figure. 5 shows different path to load drug or biomolecules on 
calcium phosphate cements [68].    
 
Figure 5. Different drug loading procedure in calcium phosphate materials [68] 
In majority of studies drug was either incorporated in powder phase or dissolved 
in liquid phase which result to drug distribution within the whole cement volume. 
Noteworthy that a more uniform drug distribution will obtained by dissolving drug in 
liquid phase. Another path is to immerse preset cement inside drug solution which 
minimize the structural changes induced by active loading. However, injectability of 
cement will be reduced by this method. Entrapping drug inside polymeric microspheres 
and blending them with the cement will avoid initial burst release associated with drug 
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loaded Bru cement. In addition, degredation of these machrophers create pores and 
support higher level of bone growth capability [68].   
Incorporation of drug has a significant effect on the setting time and final features 
of Bru cements. Drugs can prolong setting time of Bru which result in less porous 
structure and subsequently slower release kinetics. Selecting a proper drug to load on the 
Bru cement is crucial owing and should remain stable versus variations in pH and 
temperature during setting reactions. Bru has shown a good potential for releasing 
antibiotics and antiseptics such as vancomycin, doxycycline, tetracycline, ciprofloxacin, 
gentamicin and chlorhexidine and growth factors like PDGF, VEGF, RANKL13, BMP-2 
and heparin [48].  
 Other applications  
Bru have been used to fill the cancer related bone defects which supports bone 
formation more than PMMA and collagen gels [69]. Also, coprecipitation of Bru with 
magnetic nanoparticles such as ferrous chloride support the targeting and destroying 
cancer cells [70]. Ability of Bru in conducting protons as well as adsorbin proteins gives 
it the possibility to use as biosensors. For instance, detection of phenol using Bru 
combined with the enzyme tyrosinase resulted in faster signaling and higher sensivity 
respect to typical polymer and clays biosensors [71]. 
                                                 
13 receptor activator of nuclear factor kB ligand  
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CHAPTER 2 
Synthetization and Characterization of alginate-brushite in-situ hydrogel 
composites 
21 
 
2.1 Introduction 
Hydrogels, 3D cross-linked networks of water-soluble polymers, due to their 
well-known biocompatibility, and microporous structure, with tunable porosity and pore 
size, have emerged as versatile and viable platforms for several biomedical applications, 
such as sustained drug release, targeted drug delivery, tissue engineering and regenerative 
medicine [72, 73]. Among natural hydrogels, Alg has been widely studied due to its 
biocompatibility, biodegradability, and low cost [3]. Structural similarity of Alg 
hydrogels with the ECM14 has made Alg a promising scaffold biomaterial [1, 74]. 
Moreover, Alg has been widely used as a carrier for the controlled release of drugs due to 
its low immunogenicity and its mucoadhesive properties [75]. However, hydrogels, 
including Alg, present several limitations, such as low tensile strength, high water content 
and large pore size, which could finally result in low drug loading efficiency of water 
soluble drugs and relatively rapid drug release [76]. 
Several studies have been focused on enhancing hydrogel properties in terms of 
drug release for extended periods of time with controllable release kinetics or self-
regulated release [77-80]. In order to reduce drug release rates, different strategies can be 
adopted based on promoting the interaction between drug molecules and hydrogel matrix, 
increasing the number of cross-links which will result in decreasing the swelling ratio, 
and/or increasing the diffusive barrier through the hydrogel matrix via the development 
                                                 
14 extra-cellular matrix 
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of composite matrices [16, 76, 81, 82]. An Alg-CNT15 composite hydrogel has been 
proposed to this purpose [83]. However, the composite matrix should not affect the 
structure and morphology of the Alg and also must not result in cytotoxic behavior. In 
this respect, the development of Alg composite hydrogels based on the inclusion of 
calcium phosphate is interesting. Calcium phosphates have been widely used in bone 
tissue engineering, since they provide a preferred substrate for cell attachment and 
expression of osteoblast phenotype [84]. Moreover, calcium phosphates have been 
proposed for their use as implantable drug delivery systems for local antibiotic treatment 
of bone infections [68, 85-87]. 
There are few published work on Alg -calcium phosphate materials, to our 
knowledge, mainly focusing on Alg -hydroxyapatite composites [88, 89]. Recently Amer 
et al [90]have proposed a new hybrid material based on Alg -Bru and Alg -monetite.  
Bru (dicalcium phosphate dihydrate) and Mon16 (dicalcium phosphate) are two 
calcium phosphate materials can be resorbed under physiological conditions. However, 
their mechanical properties seem to be weak [91, 92]. Dicalcium Phosphate materials 
have been deeply studied for applications in bone tissue engineering, cancer therapy, and 
drug delivery [48]. Monetite can be precipitated by dehydration of Bru [93] or by 
modifying the precipitation conditions of Bru cements. This occurs when the cement is 
                                                 
15 carbon nanotubes 
16 Monetite  
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prepared in a condition that available water is limited [94], in presence of metallic ions 
like Sr [95], and when the pH is maintained at very low values [96]. Despite the fact that 
monetite is more resorbable than Bru and does not convert easily to apatite, calcium 
phosphate cements usually set to form Bru for kinetic reasons, as the precipitation of Bru 
is an exothermic reaction, while the monetite formation is endothermic [97]. Also, 
mechanical properties of Bru phase is generally better than the monetite [98]. 
2.2 Materials and methods 
2.2.1 Raw Materials 
Sodium alginate  from brown algae, having a viscosity of 15-20 cps at the 
concentration of 1% in water (w/v), calcium nitrate tetra hydrate [Ca(NO3)2.4H2O, 99%], 
diammonium hydrogen phosphate [(NH4)2HPO4, 98%], hydrochloric acid (HCl), sodium 
hydroxide (NaOH), Dulbecco Modified Eagle’s Medium (DMEM), fetal bovine serum 
(FBS), phosphate buffered saline (PBS), [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] (MTT) were purchased from Sigma-Aldrich. MG-63 
(human osteosarcoma) was obtained from the National Cell Bank of Iran (NCBI), Pasteur 
Institute of Iran. In addition, 96-well microtiter plates for cell culture were supplied by 
Nunc, Denmark. All reagents were used without any purification. Water, used in the 
experiments for the solutions preparation and washing, was purified by Milli-Q system 
and had resistance of 18.2 MΩ cm.  
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2.2.2 In-situ synthesis of Alg-Bru composites 
Alg was added slowly to di-ammonium hydrogen phosphate solution, having a 
concentration 0.1 M in pure water, under stirring rate of 600 rpm to a final concentration 
of 1% (w/v) in water. The obtained solution stirred for 2 h at room temperature. Then, the 
Alg solution was added drop-wise using a syringe equipped with a 0.800 mm needle to 
0.25 M Ca(NO3)2.4H2O cross-linking solution . The pH values of both solutions were set 
at different values ranging from 3 to 9, using HCl and NaOH (0.1 M), in order to evaluate 
the effect of the pH on the in-situ synthesis of the composite hydrogel. Cross-linked Alg-
Bru beads were formed instantly. The beads were kept in the crosslinking solution for 24 
hours to complete the crosslinking process and facilitate the growth of di-calcium 
phosphate into the beads. In order to remove excess Ca2+ ions and other impurities, the 
beads were subjected to centrifugation at 1000 rpm for 5 minutes and washed in distilled 
water. The rinsing process was repeated four times. Finally, the beads were dried at room 
temperature for 24 h and then heated at 50 ˚C overnight. Samples are referred as Alg-0.1-
X, where 0.1 is the molar concentration of the phosphate solution and X is the pH value. 
The next step was to evaluate the effect of phosphate concentration on the 
synthesis of the composite hydrogels. To this aim, different concentrations of di-
ammonium hydrogen phosphate (0.1, 0.25, 0.5 and 1 M) were tested while the pH value 
of Alg solution and cross-linking one were set at 7. Samples are referred as Alg-Y-7, 
where 7 is the fixed pH value and Y is the concentration of the phosphate solution. 
Table.1 summarizes the different preparation conditions of composite hydrogels. 
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2.2.3 Characterization 
In order to determine the phase composition of the prepared beads, a Philips PW 
1800 X-ray diffractometer with Cu-kα radiation source was used. The spectra were 
collected over the 2Ɵ range of 3˚ to 90˚ at 30 mA and 40 kV. The resultant spectra were 
compared with ICDD (JCPDS) standards number 9-0077 to characterize the phases. 
Fourier transform infrared spectroscopy was used to investigate the compounds and 
functional groups of beads using a Nicolet 380 Fourier transform infrared spectrometer 
(Thermo Fisher Scientific Inc, USA) by KBr pellet technique. A weighted amount of 
powders has been accurately mixed with KBr matrix at the concentration of 1% for each 
sample in order to obtain a standardized homogeneous mixtures. Besides, spectra were 
reported in common scale.  The spectra were obtained within the range of 400 to 4000 
cm-1 at room temperature. The surface morphology investigation was carried out via 
scanning electron microscopy with Hitachi S-2500 model. Thermogravimetric analysis, 
as well as differential thermal analysis, were performed using TG-DTA Netzsch 
Gerätebau STA 409 (Germany) in nitrogen atmosphere at the heating rate of 10 K.min-1 
in the range of 25 ˚C to 450 ˚C. 
2.2.4 In-vitro cell culture and MTT assay  
The cells were cultured in DMEM medium supplemented with 10% (v/v) fetal 
bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. The cells were 
incubated at 37˚C in humidified air with 5% CO2. Cells were plated in a multi-well (96) 
flat-bottomed plate with a density of 104 cells/well in 100 μl of culture medium. The 
sample sterilization process was carried out using UV light for 90 minutes. The rate of 
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proliferation was calculated using extracted samples based on ISO 10993-5 protocol. The 
sterilized samples were soaked into DMEM media at concentration of 0.1 g/ml and 
incubated at 37ºC for predetermined time intervals. Namely, after 3, 7 and 14 days, the 
medium was gathered for using in MTT assay. Pure culture medium, maintained under 
similar conditions was used as negative control. Cell viability was assessed using the cell 
viability assay kit MTT.  
This method is based on the principle that viable cells change yellowish MTT into 
an insoluble purple formazan crystal. The absorbance of each solution is quantified using 
scanning multiwall spectrophotometer (ELISA reader). After 24 hours, the culture 
medium in each well was removed and replaced by 90µl sample (culture medium kept in 
contact with composite hydrogels) plus 10µl FBS. The medium was removed after 24 
hours and then 100 µl of MTT solution (0.5mg.ml-1) was added into each well and 
incubated for 4 hours at 37˚C. In order to dissolve the formed formazan crystals, 100 μl 
of isopropanol was added to each well. The plate was placed in incubator for 15-20 
minutes to completely dissolve formazan crystals. Finally, the optical density of 
formazan was recorded at 545 nm using a multiwell microplate reader.  
Table 1.  Preparation conditions of different samples, the concentration of sodium Alg and 
calcium nitrate in all samples were 1(w/v) %and 0.25 M, respectively 
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Item Name (M)4 HPO2)4(NH pH of solutions 
1 Ca-Alg 0 7 
2 Alg-0.1-3 0.1 3 
3 Alg-0.1-4 0.1 4 
4 Alg-0.1-5 0.1 5 
5 Alg-0.1-6 0.1 6 
6 Alg-0.1-7 0.1 7 
7 Alg-0.1-8 0.1 8 
8 Alg-0.1-9 0.1 9 
9 Alg-0.25-7 0.25 7 
10 Alg-0.5-7 0.5 7 
11 Alg-1-7 1 7 
 
2.3 Results and discussion 
2.3.1 Preparation of composite beads 
The in-situ process was employed to prepare different formulations of Alg -Bru 
hydrogel composites. The term in-situ refers to simultaneous occurrence of Bru 
nucleation and growth, and crosslinking of sodium Alg. The Alg crosslinking process 
started immediately when Alg solution was dipped into calcium nitrate solution and 
nucleation and growth of Bru crystals was carried out via following equation: 
Ca(NO3)2 + (NH4)2HPO4 + 2 H2O                                   CaHPO4˖2H2O + 2 NH4NO3 
The Ca2+ infiltrated into hydrogel network where it would react with HPO4
2- 
which was dispersed homogeneously within Alg network. As a result Bru crystals started 
to grow in the polymeric network (Figure. 6). On one hand, dissolution of precursors 
resulted in formation of Ca2+ and HPO4
2- ions in the media which caused pH variation in 
both solutions. On the other hand, the formation of Bru is highly dependent on the initial 
pH. Hence, we investigate the impact of initial pH on the formation of Alg-Bru hydrogel 
composites and later we evaluated the impact of initial phosphate concentration at pH 7 
which is favorable for Bru formation.  
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Figure 6. Water content and dried digital images of A)Alg-0.1-7, B) Alg-0.25-7,  C)Alg-0.5-7, D) Alg-
1-7 
2.3.2 FT-IR analysis 
Figure.7 shows FT-IR spectra of the different composite samples together with 
the spectrum of reference Ca- Alg. As for Alg spectrum, the main bands are detected at 
1620 and 1425 cm-1 corresponding to the asymmetric and symmetric stretching mode of 
the carboxyl group [99]. At lower frequencies, a complex envelop of bands in the range 
1200-1000 cm-1 is due to the C-O and C-C stretching modes of the carbohydrate chain. 
The very weak peak at 2930 cm-1 is assigned to C-H stretching mode [99]. Bru phase is 
characterized by two doublet of peaks at 3165, 3277 cm-1 and 3491, 3543 cm-1 assigned 
to O-H stretching modes of crystallization water molecules [100]. Correspondingly, the 
absorption peak at 1651 cm-1 relates to the H-O-H bending mode [101]. The bands of 
phosphate group PO4, i.e. P-O stretching modes, were detected at 1136, 1061 and 987 
cm-1 [90, 100]. The P-O-H stretching mode and P-OH bending mode peaks can be 
A B C D 
A B C D 
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detected at 1221 and 874 cm-1, respectively [101]. Finally, peaks at 667, 579 and 528 cm-
1 are due to P-O deformation mode of phosphate group [100]. 
The impact of pH on the Alg has been studied extensively by researchers and they 
reported that the pKa of Alg is around 3.5 [102]. Hence, Alg mostly negatively charged 
in the pH range of 3-9. Besides, we have spectroscopic evidences of deprotonated 
carboxyl group (bands at 1425 and 1620 cm-1) in the all pH value used in this experiment. 
As we can see in Figure. 7A pH value has a significant impact on the formation of Bru 
into Alg matrix. The characteristics peaks of brushite are detected in the spectra 
corresponding to composites from pH value of 6 to 8. It is clear that at the pH value of 
less than 6, regardless of some weak phosphate peaks (Figure. 8), the FT-IR spectra are 
pretty similar to that of Ca-Alg. As we increased the pH value from 7 to 8, the relative 
intensities of diagnostic Bru peaks (namely band at 1650 cm-1) evaluated in comparison 
with Alg peaks (namely band at 1425 cm-1) slightly increased while width of peaks 
decreased. This can attributed to strengthening of phosphate bonds at the pH value of 8 
(for instance by increasing crystallinity of phosphate phase which was confirmed by 
XRD results) [103]. On the other hand, the characteristic O-H stretching bands of water 
at 3163, 3321, 3479, and 3549 cm-1 almost disappeared at the pH value of 9. Increasing 
pH values by adding NaOH can also affect the Alg component, for instance by forming 
Na- Alg, thus explaining some changes in the region of 1650-1400 cm-1 of the spectrum 
[102]. 
Figure. 7B represents the effect of Phosphate concentration on the in-situ 
formation of Alg-Bru composites at constant pH value of 7. All the spectra showed the 
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characteristics peaks of Bru and have very similar shape and width. Moreover, the best 
results in terms of sharpness of Bru IR peaks have been obtained at the concentration of 
0.25M of phosphate. As expected, increasing the relative concentration of phosphate 
(from 0.25M to 1 M), results in decreasing the relative intensities of the carboxylate 
bands at 1620 and 1425 cm-1 in comparison to Bru characteristics bands. 
 
 
Figure 7. FT-IR spectra of fabricated samples A) different pH value, B) different phosphate 
concentration 
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Figure 8. FT-IR spectra of Ca-Alg and samples prepared at pH values of 3-5 in the range of 400-2000 
cm-1 
 
The comparison of the composite spectrum Alg-0.25-7 with spectra of pure Bru 
and Ca- Alg has been reported in Figure. 9 in order to study the interactions of these 
components. Corresponding bands of Alg carboxylate groups at 1620 and 1430 cm-1 are 
detected at the same wavenumbers in both the composite spectrum and the pure Alg 
spectrum, showing that there are no changes in the coordination of the COO- group 
following Bru formation. C-H stretching bands at about 2930 cm-1 are indeed weakened 
in the spectrum of the composite, and this effect can be due to the lowering amount of 
organic compound. 
On the other hand, bands due to Bru phosphate groups in the range of 1200-900 
cm-1 are not affected by the co-presence of Alg, maintaining the same shape and 
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wavenumbers in both reference Bru and composite spectra. These data suggest that the 
interaction of Alg with Bru phase is weak. 
 
Figure 9. FT-IR spectra of: Ca- Alg, Bru, and Alg-0.25-7 composite 
2.3.3 XRD analysis 
 The resultant XRD spectra are illustrated in Figure. 10. These spectra were 
compared with that of standard Bru JCPDS card (9-0077). It is clear that the samples 
were completely amorphous at the pH values lower than 6. At pH value of 6 the Bru 
crystals started forming and the best conditions for their formation are obtained at the pH 
value of 7 and 8 (Figure. 10A). Bru in these preparation conditions had monoclinic 
crystalline structure with the following crystallographic parameters: a= 6.363 Å, b= 
15.190 Å, c= 5.815 Å, α= γ= 90˚, and β= 118.5˚. In addition, as the pH value exceed 8, 
reductions in the intensity of characteristics peaks, especially at 2Ɵ of 20.9˚, 29.25˚, and 
34.16˚, and increases in the width of them were noticeable. This showed us that the 
degree of crystallinity would be lower if the pH value exceeded 8.  
33 
 
Figure. 10B demonstrates the effect of phosphate variation on the XRD spectrum 
of the samples. All the spectrum are quite in a good accordance with JCPDS card (9-
0077). Besides, it is worth to notice that as the concentration of phosphate increased the 
intensity of characteristics peaks increased while the width decreased. We can say that 
these samples were more crystalline. The main reason for this compounds to be more 
crystalline seems to be the fact that the relative concentration of amorphous phase, Alg, 
significantly decreased as the concentration of phosphate increased.    
The (020), (021), (040), (041), (-221), (220), (022), (151), (-260), and (241) 
diffractions were used to calculate mean crystallite size, t, according to Scherrer‘s 
equation [104]: 
    
Where k refers to a dimensionless shape factor ,the Scherrer constant, (generally assumed 
to be 0.9), λ is the wavelength of X-ray radiation, β is the line broadening at half the 
maximum intensity in radians, and θ is the Bragg angle. The calculated mean crystallite 
size for the sample prepared at pH 7 and 0.1 M of phosphate was 31.7 nm. 
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Figure 10. XRD spectra of fabricated beads A) different pH value, B) different phosphate 
concentration 
2.3.4 Thermal behavior 
Thermal behavior of two dried composite samples, prepared at pH 7 and 8, were 
studied performing TGA and DTA. The TGA results revealed a continuous weight loss in 
the range of 30 to 700 ˚C for both samples. The accurate amount of total weight loss for 
the samples prepared at pH of 7 and 8 were 49.3% and 46.2, respectively (Figure. 11A). 
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We can see that around 10% of weight loss from 60 ˚C to 180 ˚C corresponds to water 
loss in the transformation of DCPD to DCP [90, 105]: 
 CaHPO4.2H2O                                CaHPO4 + 2H2O 
The rest of weight loss can be assign to the decomposition of the organic moieties 
[106] and to the transformation of DCP to calcium pyrophosphate through the following 
reaction [105]: 
2CaHPO4                                                   Ca2P2O7 + H2O 
Forest et al [107] have investigated on thermal decomposition of Bru and they 
concluded that 21.97 % of Bru weight had been lost due to complete transformation of 
DCPD to DCP and DCP to calcium pyrophosphate at the temperature range of 56-514˚C. 
Besides, other studies conducted on evaluating thermal behavior of sodium Alg and 
calcium Alg mentioned that about 55% mass loss was due to dehydration and 
decomposition of Alg in this temperature range [108, 109].  
In addition, the DTA results indicated two endothermic and three exothermic 
phenomena in the heating range. As we can see in the Figure. 11B in the case of Alg-0.1-
8 the endothermic peak at 124 ºC can be assigned to evaporation of water molecules 
trapped into small structural pores. Besides, endothermic reaction at 189 ºC corresponded 
to dehydration of Bru. The very small endothermic peak around 319 ºC is related to 
formation of calcium pyrophosphate. Finally, degradation and decomposition of Alg 
matrix to carbonate materials like CaCO3 is responsible for the sharp exothermic peak at 
227 ºC  and wide exothermic peak at 572 ºC [108].  
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The phenomena discussed above occurred in both Alg-0.1-7 and Alg-0.1-8 
samples although, slightly shifted toward higher temperatures in the former sample. This 
effect suggests that the samples Alg-0.1-8 had more stable crystalline structure than the 
other samples and these results are in a good accordance with the XRD results. 
Figure. 12 presents derivate thermogravimetric (DTG) spectra of pure Alg, Bru, 
and Alg -Bru composite prepared at pH 8. The comparison DTG pattern of Alg-Bru 
composite with reference materials showed that the main weight loss can be detected in 
the range of 150-300˚C. Neither thermal degradation of pure Alg nor Bru demonstrated 
this kind of phenomena at this temperature range. The complexity of this peak suggests 
that several decomposition steps occured simultaneously, such as the degradation of the 
organic component through the extensive breaking of glycosidic bonds which resulted in 
the formation of small molecules and carbonaceous material, and the Bru dehydration. 
Therefore, the overall decomposition of the composite material seems to be more 
complex and since it shifted to a lower temperature, in comparison with pure Alg, we can 
conclude that there is a catalytic effect of the Bru materials on this phenomena. These 
results confirm the existence of specific interaction (however it is weak) between the 
organic and inorganic components of Alg-Bru hydrogel composite. 
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Figure 11. Effect of pH value on thermal analysis of Alg -Bru samples A) TGA B) DTA 
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Figure 12. DTG spectra of Bru, Alg, Alg -Bru composite 
2.3.5 Morphological study 
Figure. 13 represents the effect of phosphate concentration on the morphology of 
formed Bru crystals within the Alg matrix.  The pictures were taken at three different 
magnifications of 500x, 1000x, and 2000x. The morphology of Bru crystals in both 
samples was plate-like aggregates in multilayers. The morphology of formed Bru was in 
a good agreement with previous reports [110, 111]. The dimensions of the crystals were 
almost the same in both samples, 50 μm in length and 20 μm in width. Furthermore, the 
thickness of the plate-like particles was around 100 to 200 nm (Fig. 14).   
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Figure 13. SEM micrograph of Alg-0.1-7 (A), and Alg-0.25-7 (B) at three different magnification of 
500x, 1000x, and 2000x 
 
Figure 14. SEM image of the Bru crystals thickness in Alg-0.25-7 sample 
A 
B 
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2.3.6 In-vitro characterization 
As shown in Figure. 15A, and Table. 2, cell viability was observed to grow 
smoothly throughout the incubation period of 3 to 7 days. All samples except those 
prepared at pH 7, 8, and Ca-Alg were toxic. According to XRD and MTT results we 
observed that samples with the crystalline structures ended up in biocompatible response. 
In other words, the residual phosphate in samples prepared at the pH value of 3-6 reacted 
with H+, Figure. 8, in culture media and consequently decrease the pH value of culture 
media. Therefore, the main reason for this samples being toxic was inappropriate pH 
value of culture media and lack of favorable conditions for cells to be proliferated. On the 
7th day the calculated growth for the biocompatible samples were higher than negative 
control and Ca-Alg (p<0.05). Although these samples showed a downward viability trend 
from day 7 to 14, the rate of viability was almost equal ,higher than 90%, to negative 
control and higher than that of Ca-Alg (p<0.1). 
Figure. 15B, and Table. 3, demonstrates the effect of phosphate concentration on 
the biological responses of Alg -Bru composite samples. The proliferation rate showed an 
upward trend from day 3 to 7. However, this was followed by a smooth decrease in 
proliferation rate at the end of day 14th. All the samples were biocompatible and they 
supported almost equal value of negative control after 14 days. The cell viability for all 
Alg-Bru hydrogel composites were higher than that of Ca-Alg sample.  
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Figure 15. Cell viability of the extracted samples at three different time intervals A) different pH 
value, B) different phosphate concentration. *p<0.01, **p<0.05, and ***p<0.1 compared to control 
Table 2. Statiscla results of Cell viability of samples prepared at different pH value after 3, 7, 
and 14 days 
Item Name Viability (%) 
3 days 7 days 14 days 
1 Control 100 100 100 
2 Ca-Alg 85.36 ± 10.12 89.45 ± 5.23 84.14 ± 7.45 
3 Alg-0.1-3 22.21 ± 3.82 18.34 ± 0.61 14.84 ± 0.91 
4 Alg-0.1-4 34.53 ± 2.63 31.36 ± 3.83 35.10 ± 9.78 
5 Alg-0.1-5 32.15 ± 4.44 21.66 ± 4.64 15.87 ± 3.99 
6 Alg-0.1-6 55.47 ± 3.59 56.46 ± 4.90 41.74 ± 8.44 
7 Alg-0.1-7 96.85 ± 4.19 100.51 ± 6.51 90.39 ± 3.49 
8 Alg-0.1-8 100.38 ± 4.53 101.74 ± 8.98 98.24 ± 6.89 
9 Alg-0.1-9 68.14 ± 3.37 68.76 ± 9.99 41.17 ± 7.31 
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Table 3. Statistical results of Cell viability of samples prepared at different pH value after 3, 
7, and 14 days 
Item Name Viability (%) 
3 days 7 days 14 days 
1 Control 100 100 100 
2 Ca-Alg 85.36 ± 10.12 89.45 ± 5.23 84.14 ± 7.45 
3 Alg-0.1-7 96.85 ± 4.19 100.51 ± 6.51 90.39 ± 3.49 
4 Alg-0.25-7 103.59 ± 1.61 107.32 ± 6.08 
 
94.87 ± 10.53 
5 Alg-0.5-7 102.22 ± 2.58 
 
107.43 ± 4.04 97.34 ± 8.58 
6 Alg-1-7 104.71 ± 2.53 107.71 ± 9.05 103.62 ± 5.78 
2.4 Conclusions 
In this study a deep characterization of process parameters for the in-situ synthesis 
of Alg -brushite composite hydrogel was carried out. This hydrogel composite has a 
potential to use in different biomedical applications including drug delivery and bone 
cements due to excellent biocompatibility. The Bru crystals can act as a barrier to avoid 
leaking of drugs from Alg network and also burst release of drug by improving swelling 
behavior of this compound. In addition, since the synthetize process was carried out at the 
room temperature, it will be a good method to capsulate temperature sensitive drugs. The 
composite hydrogels were successfully prepared via complexation of Alg -Phosphate by 
calcium ions at room temperature. The Bru crystals were successfully formed inside the 
Alg matrix at pH ranging from 6-8 as evidenced by FT-IR and XRD. In addition, 
according to TGA, DTA, XRD, and FT-IR it was revealed that the optimum conditions 
and more stable structure were obtained at pH range of 7-8. XRD and FT-IR results 
indicated the presence of Bru crystals inside the Alg matrix as the concentration of 
phosphate increased. The in-situ formed Bru crystals had plate like structure with the 
thickness of 100-200 nm. Finally, MTT results, over the incubation time period of two 
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weeks, revealed that just the crystalline samples were non-toxic and all of them had a 
higher proliferation rate in comparison with Ca- Alg. The applications of this material are 
under investigation in our lab. 
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CHAPTER 3 In-situ synthetized hydrogel composite based on alginate and brushite 
as a potential pH sensitive drug delivery system 
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3.1 Introduction 
In the past decade, DDS have attracted tremendous attentions as an optimized 
therapeutic method of drug administration. In fact, DDSs seek to control the release 
profile of drugs in order to have a sustained therapeutic level and to minimize adverse 
side effects [112]. Of all materials proposed for the fabrication of DDS, hydrogels are 
seem to have piqued more interest mainly because of their biodegradability, 
biocompatibility, and stimuli responsive characteristics [113]. Several polymers such as 
Alg [114], chitosan [115], gelatin [116], PVA17 [117], and PEG18 [118] have been widely 
used as carriers for drugs, cells and proteins. However, such applications of pure 
hydrogels have experienced burst release since hydrogels contain high amount of water 
and possess weak mechanical properties[119]. 
Alg is a promising biopolymer which has numerous biomedical applications 
ranging from wound healing and drug delivery to cell transplantation in tissue 
engineering. Alg exhibits pH sensitive swelling behavior, thereby making it a potential 
candidate for oral administration of drug, .This is mainly due to the fact that it protects 
the entrapped drug in the gastric fluid and releases it in intestine fluid [120]. Noteworthy, 
though, that Alg has been reported to possess a low encapsulation efficiency of water-
soluble drug caused by drug leakage during the crosslinking procedure. Two additional 
                                                 
17 polyvinyl alcohol 
18 poly (ethylene glycol) 
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factors that restrict the use of this polysaccharide are its quality of rapid integration in 
intestine fluid and its highly porous structure.  
To bypass these limitations, increasing the number of cross-links may be 
advisable [16, 81, 82, 121]. One more solution is improving the mechanical properties via 
introducing other phases into the hydrogel matrix. This far, most studies have sought to 
improve the mechanical properties by fabricating biopolymer-inorganic reinforcement 
hydrogel composites as a result of restricting polymeric chain movements [83, 122-124]. 
It also seems that further improvements are achievable by changing the type of 
reinforcement and also, the content of polymer, and inorganic compound. Noteworthy 
that such incorporation must neither affect the structure of the Alg nor result in cytotoxic 
behavior [83]. 
To prolong the release profile, Calcium phosphate materials, mainly 
hydroxyapatite, have been incorporated into Alg. Previously Zhang et al [89] showed that 
in-situ synthetized hydroxyapatite micro particle within Alg restricted the polymer chain 
movement and consequently decreased the swelling ratio. It was also demonstrated that 
the incorporating of hydroxyapatite augmented the entrapment efficiency and prevented 
burst release. Along the same line, Ilie et al [125] also studied the release of ascorbic 
acid, Vitamin C, from Alg-hydroxyapatite composite and demonstrated the significant 
impact of hydroxyapatite on gradual release of ascorbic acid. In another study, 
hydroxyapatite nanoparticles were introduced into Alg-poly (vinyl pyrrolidone) blends 
and diclofenac sodium release was investigated from several compositions of these 
carriers [126]. The release profile indicated that the presence of nanohydroxiapatite 
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particles not only did improved the loading efficiency, but it also remarkably decreased 
the amount of released drug. 
Previously, we investigated the in situ synthetization of Alg- Bru composite 
hydrogel and optimized the fabrication method. Moreover, we evaluated the 
biocompatibility of these materials respect to osteoblastic cell and observed a significant 
improvement in cell proliferation with respect to calcium Alg [127, 128].  
3.2 Materials and methods 
3.2.1  Raw materials 
All the chemical reagents: sodium Alg from brown algae with a viscosity of 15-20 
cps at the concentration of 1 wt%, calcium nitrate tetrahydrate [Ca(NO3).4H2O, 99%], 
diammonium hydrogen phosphate [(NH4)2HPO4, 98%], hydrochloric acid (HCl), sodium 
hydroxide (NaOH), potassium dihydrogen phosphate (KH2PO4), phosphate buffered 
saline (PBS) tablets, and Ibu19 sodium salt were supplied by Sigma-Aldrich. All reagents 
were used without any purification. A Milli-Q system with the resistance of 18.2 MΩ cm 
was used to purify the water which was eventually used for preparing solutions and 
washing steps. 
                                                 
19 Ibuprofen 
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3.2.2 Beads preparation 
A series of Alg-Bru beads were prepared according to the following procedure. 
First, a predetermined amount of di-ammonium hydrogen phosphate was dissolved in 10 
ml of purified water at room temperature and 600rpm. Then, accurately weighted 
amounts of sodium Alg were added slowly to the above solution at a stirring rate of 
600rpm. This solution was subsequently stirred for two hours to ensure the complete 
dissolution of Alg. After that, the solution was dripped into the crosslinking solution (0.2 
M of calcium nitrate) at room temperature at a gentle stirring rate (50 rpm) through a 
syringe equipped with a 0.8 mm needle. The initial pH of the solutions was maintained at 
7.5 using HCl and NaOH (0.1M). White beads were formed immediately and maintained 
in the crosslinking solution to ensure that the Bru crystal growth and crosslinking process 
were properly accomplished.  Thereupon, the samples were centrifuged at 1000rpm for 5 
minutes and rinsed 4 times to remove excess Ca2+ and other impurities. Finally, the 
samples were kept for 24 h at room temperature followed by placing them in the oven at 
45˚C for 12 hours.  
In order to prepare Ibu loaded beads, predetermined amounts of Ibu were added to 
the aqueous solutions composed of di-ammonium hydrogen phosphate and sodium Alg. 
The solutions were stirred for 1h to ensure that Ibu completely dissolved in the media. 
The rest of the procedure, including crosslinking and washing steps, were done as 
described above. In addition, calcium Alg samples were also prepared following the 
above procedure with the exception of adding no (NH4)2HPO4 to the Alg solution. There 
were some factors which had significant impacts on the swelling behavior, drug loading, 
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and drug release behavior. These factors included the initial concentration of Alg, and 
primary concentration of phosphate precursor. The varying preparation conditions were 
summarized in table 4. 
 
 
 
 
Table 4. Preparation conditions of Alg-Bru composite beads and their influence on swelling 
ratio and storage modulus 
Item Sample Sodium alginate 
(wt %) 
(NH4)2HPO4 
(M) 
Ca(NO3).4H2O 
(M) 
Storage 
modulus at 
85 Hz (kPa) 
1 Alg 1.5 1.5 --- 0.2 30.5±3.17 
2 Alg 1- P 
0.1 
1 0.1 0.2 35.2±3.54 
3 Alg 1.5- P 
0.1 
1.5 0.1 0.2 58.83±3.42 
4 Alg 2- P 
0.1 
2 0.1 0.2 78.86±6.53 
5 Alg 2-P 0.2 2 0.2 0.2 119.47±6.35 
6 Alg 2-P 0.4 2 0.4 0.2 73.93±14.84 
7 Alg 2 2 0.2 0.2 70±8.21 
 
3.2.3  Characterization 
A Nicolet 380 Fourier transform infrared spectrometer (Thermo Fisher scientific 
Inc, USA) was used to obtain FT-IR spectra through the KBr technique and to evaluate 
the formation of composite and the interactions between Ibu and composite materials. 
The spectra were collected within the range of 400 to 4000 cm-1. In order to identify the 
inorganic phase of beads as well as presence of the entrapped drug, beads were subjected 
to X-ray diffraction (XRD) test. Therefore, A PANalytical Empyrean x-ray 
50 
 
diffractometer with irradiation source of Cu-Kα was used to collect the spectra over the 
Brag angle, 2Ɵ, range of 5-60 at a scan rate of 2˚ per minute. The obtained spectra were 
compared with those of standard JCPDS numbers for Bru (9-0077) and Ibu (32-1723). A 
JSM-6490LA scanning electron microscopy (SEM- JEOL Ltd, Japan) was used to 
investigate the dispersion of Bru crystals in Alg matrix and morphology of Bru crystals. 
3.2.4 Dynamic mechanical analysis (DMA) 
A typical test to gather information about mechanical properties of hydrogels is 
dynamic mechanical analysis (DMA). The mechanical properties of different hydrogel 
samples were obtained using a custom-made device, Figure. 16 of supporting 
information, developed at DICCA laboratory of University of Genova. 
 
Figure 16. Schematic of the DMA test equipment to obtain storage and loss modulus 
The experimental set-up posses following items: 
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 Fixed head movable by a screw, so that the distance between the two 
plates can be adjusted accordingly with the sample dimensions. 
 Electrodynamic mini-shaker (Brüel & Kjær type 4810): it is provided with 
a permanent field magnet and it applies oscillating stimuli to the implant. 
 Power amplifier (Brüel & Kjær type 2706): it controls the mini-shaker and 
the amplification magnitude of the sinusoidal vibrations can be set through 
a potentiometer. 
 Force transducer: it consists of a piezoelectric load cell, which generates a 
charge signal (proportional to the applied force) as a response to the 
mechanical stimulus applied by the shaker. 
 Laser vibrometer (Complete Polytec Laser Vibrometer System OFV 
3000/302 with Nikon Lens Sensor Head Version): it’s located above the 
experimental set-up and it measures the displacement. This component 
works on the principle of optical interference: a laser 
 Beam is aimed towards a target plate, leading to light scattering. The light 
that has been scattered is then collected and it interferes with a reference 
beam. 
 Metal plate placed over the mini-shaker and used as a reflecting surface 
for the laser beam. 
 Sensor signal conditioning (482C series, PCB Piezotronics): it amplifies 
and converts the signal acquired by the force transducer into an electrical 
one. 
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 Labview software responsible for the functioning of the instrument, and 
for storing, displaying and processing measurement data. The instrument 
is isolated from vibration by blocks of cement and rubber supports. 
 All the tests were performed in compression within the range of 5-100 Hz with 
an initial pre-deformation of 20% of the sample diameter. The test consists in a sinusoidal 
vertical oscillation obtained with a shaker (Brüel & Kjӕr, Mini-shaker, type 4810). This 
sinusoidal oscillation causes deformation of the samples as a result of the cylindrical 
indenter action. The corresponding sinusoidal oscillating force (dynamic oscillating 
stimulus) is measured with a force transducer (PCB Piezotronic, Load cell, model 208 
M116) with the accuracy of ͂10
-3 N. Also, the displacement with a resolution of 0.01 μm 
is measured through a laser vibrometer (Polytec OFV 3000 vibrometer controller) 
focused on the oscillating plate. Table. 5 of supporting information summerized the set-
up parameters of the device. 
Table 5. set up parameter for the DMA tests 
Initial deformation 20% of initial diameter 
Amplitude 5.00 V 
Start frequency 5.00 Hz 
Stop frequency 100.00 Hz 
Stimulus 9.73 N/V 
 
The dynamic complex modulus, E*, defines as the stress to strain ratio of the 
materials placed in the vibration conditions. 
E*=            (1) 
The complex modulus can be split in two parts according to the Equ.1: 
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E*= E’ +iE”          (2) 
where 
E’ = E*cos δ =  cos δ         (3) 
 is the storage (or elastic) modulus 
E” = E*sin δ =  sin δ         (4) 
is the loss (or damping) modulus. 
The Storage Modulus represents the elastic component of the material and it 
indicates the amount of energy stored during a loading cycle, while the Loss Modulus 
represents the viscous component and it is proportional to the energy dissipated during 
the same loading cycle. Both E’ and E” are dynamic material-specific characteristics that 
depend on the frequency. The loss factor (Q–1) is the ratio of  (tan δ) and represents 
the mechanical damping in a viscoelastic system. The phase angle δ is the phase 
difference between the dynamic stress and the dynamic strain in a sample subjected to a 
sinusoidal oscillation. For a viscoelastic material δ falls into the following range: 
0 < δ < π/2 
 The behavior of a material is conventionally called solid-like when tan δ < 1 at a 
given frequency, otherwise it is defined as liquid-like.  
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3.2.5 Swelling ratio  
The swelling ratio of the micro beads was calculated gravimetrically by 
measuring their weight gain in phosphate buffer saline (PBS) at pH 7.4. Accurately 
weighted (W0) of dried micro beads were immersed in PBS at 37˚ C. After predetermined 
time intervals (30, 60, 90, 120, 180, 240, 300, and 360 minutes), the beads were filtered 
from the solution through a Millipore 0.22 μ filter equipped with a pump to remove extra 
liquid and weight immediately (Wt). The following equation will give us swelling ratio 
(SR) of micro beads at different time. 
SR = )  
3.2.6 Drug content 
In order to estimate drug encapsulation efficiency, 10 mg of dried beads was 
placed and shaken in 10 ml of PBS for 24 h at 37˚ C, and then sonicated (FALC-
HK2200, Italy) for 30 minutes in order to ensure a complete Ibu release. After that, the 
solution was centrifuged and filtered using Minisart 5.00 μ filter. The actual amount of 
Ibu was determined using a UV visible spectrophotometer (Jasco V-570) at the 
wavelength of 264 nm and a calibration curve in PBS. Then, the entrapment efficacy (% 
EE) for Ibu was calculated according to the following equation: 
% EE =   
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3.2.7 In-vitro drug release experiment 
In vitro drug release of Ibu from the different formulation of Alg-Bru samples 
was carried out at 37 ˚C using Heraeus incubator equipped with an 
IKALABORTECHNIK shaker at the rotation speed of 100 rpm in PBS. The first two 
hours of experiment was carried out in a PBS solution at pH 1.5 (prepared by dissolving 
0.05M of KH2PO4 and adding HCl to adjust the pH) and followed by 8 hours in PBS 
solution at pH 7.4 to simulate the behavior of the carrier in the gastric fluid and intestine 
fluid, respectively. 10 mg of dried hydrogel samples were immersed in a 10 ml of release 
media.  After predetermined time intervals, 5 ml of solution was withdrawn and replaced 
with equal amount of fresh media. These withdrawn samples were subject to UV visible 
spectrophotometer at 264 nm. The IBP release percentage was calculated according to 
following equation: 
IBP release percentage = (Rt / R0) × 100 
Where Rt is the released amount of IBP at time t and R0 is initial amount of Ibu 
encapsulated in the beads. 
3.3 Result and Discussion 
Previously we investigated the mechanism of in-situ fabrication of these hydrogel 
composites [127, 128]. Briefly, two simultaneous phenomena occurred as a result of in-
situ synthetized method which was used to fabricate the hydrogel composites. First, the 
nucleation and growth of Bru crystals inside the Alg matrix occurred followed by 
crosslinking of the polymeric network and formation of the beads 3D structure.  Ibu was 
loaded into the beads by dissolving it in the solution containing sodium Alg and 
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(NH4)2HPO4. The loading procedure started as soon as the polymeric solution was 
introduced to the crosslinking solution in a dropwise manner. The homogeneous 
dispersion of Ca2+ and PO4
3- ions in both solutions yield to uniform dispersion of Bru 
crystals within the Alg matrix. As reported before  [89] the concentration of (NH4)2HPO4 
and sodium Alg have a significantly impacts on the mechanical properties, swelling ratio, 
entrapment efficiency, and in–vitro release behavior. Therefore, we investigated the 
influence of these factors on the mentioned characteristics. In addition, the initial drug 
content is another significant factor owing to its interaction with the carrier in the 
molecular scale. Hence, we studied the loading efficiency and its subsequent in-vitro 
release for three different concentrations of drugs. To our knowledge, no study was 
conducted on using the in-situ synthetized Alg-Bru hydrogel composite as a drug carrier. 
Therefore, structural and mechanical characterizations of these hydrogel composite and 
investigation of drug-carriers interactions are of crucial importance. 
3.3.1 Characterization 
 FT-IR analysis 
Figure. 17 shows the IR spectra of Alg -Bru hydrogel composite and Ibu loaded 
Alg-Bru hydrogel composite in comparison to spectra of pure reference materials, i.e. 
calcium Alg, Bru and, Ibu. In the spectrum of the Ibu-loaded composite several bands are 
detected characterizing both the hydrogel matrix and the drug molecule. In the high 
frequency region, the two doublets are diagnostic peaks of Bru which corresponds to O-H 
stretching peaks of the two structural water molecules [100]. These peaks in our spectrum 
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were detected at 3164, 3278 cm-1 and 3496, 3546 cm-1. Furthermore, the corresponding 
sharp peak to the H-O-H bending mode was observed at 1640 cm-1 [101]. The peaks at 
1133, 1056 and 985 cm-1 represent the specific peaks of PO4 [90, 100]. Besides, the 
bands at 1226 and 869 cm-1 indicate stretching and bending mode of P-OH, respectively 
[101]. P-O deformation mode of phosphate group were observed at 659, 574 and 526 cm-
1 [100]. On the other side, the broad bands centered at 1640 and 1425 cm-1 represent the 
asymmetric and symmetric stretching mode of the carboxyl group in Alg spectrum [99]. 
These peaks appeared as very weak absorption peaks due to partial masking by the Bru 
strong features. Also, the complex peaks in the range of 1000-1200 cm-1 relate to C-O and 
C-C stretching modes of Alg chain [99] are overlapped with bands of the phosphate 
group.  
As for the Ibu molecules loaded in the complex matrix, the band at 1720 cm-1 is 
assigned to C=O stretching vibration of the undissociated (acidic) COOH group. In 
addition, weak and sharp bands at 1508, 1461, and 1384 cm-1 can be attributed to C-C 
vibrational modes in phenyl ring and vibration of C-H bond in the Ibu structure [129, 
130]. In the same figure, the spectrum of Ibue in form of Na-salt is reported for 
comparison. This spectrum is characterized by two strong bands at 1550 and 1412 cm-1 
assigned to the asymmetric and symmetric vibrational modes of the –COO- group.  
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Figure 17. FT-IR spectra of calcium alginate (Ca-Alg), brushite (Bru), alginate-brushite (Alg 2-P 
0.2), ibuprofen (Ibu), and ibuprofen loaded alginate-brushite (Alg 2-P 0.2-2) 
The subtraction spectrum of [Alg 2-P 0.2-2] – [Alg 2-P 0.2] is reported in Figure. 
18 of supporting information evidenced two main effects arising from the drug 
entrapment. i) the two strong bands appearing in the spectrum of the pure Na-Ibu due to 
asymmetric and symmetric stretching modes of the salt are not detected anymore and 
replaced by a sharp band at 1720 cm-1 (C=O of the –COOH group). ii) Other bands of 
the drug molecules, for instance bands due to alkyl chain and aromatic ring, are clearly 
detectable and only very slightly affected by the interaction with the composite. A likely 
explanation is the pH decrease during Bru formation in the matrix [131] which leads to 
the formation of free COOH groups in the acidic form of Ibu. Loading acidic form of the 
drug on the beads might be more favorable than anionic form due to reduction in the 
electrostatic repulsion with negatively charged Alg chains. 
A
b
so
rb
an
ce
 (
a.
u
.)
 
 
59 
 
 
Figure 18. FT-IR spectrum of acidic Ibu and subtraction spectrum of [Alg 2-P 0.2-2] – [Alg 2-P 0.2] 
 X-Ray diffraction 
Figure. 19 shows the XRD patterns of Alg-Bru hydrogel composite, Ibu, and Ibu 
loaded Alg-Bru hydrogel composite. The standard Bru JCPDS card (9—0077) and the 
standard Ibu JCPDS card (32-1723) were used to analyze the resultant spectra. As we can 
see in Figure. 19, those peaks marked by red * are characteristic peaks of Ibu. In addition, 
those peaks with blue * are mutual peaks of Bru and Ibu. Rest of the peaks relate to 
characteristic peaks of Bru component. Hence, the FT-IR results along with those of 
XRD confirmed that the drug successfully was entrapped by Alg-Bru beads. 
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Figure 19. XRD patterns of Alg 2-P 0.2, Ibu, and Alg-P 0.2-2 
 Scanning electron microscopy (SEM) 
The SEM micrograph of calcium Alg and Alg-Bru dried beads at different 
magnification are presented in Figure. 20A, 20B, 20C, 20D, 20E and 20F to investigate 
the impact of phosphate group incorporation on the surface morphology of beads. In 
addition, Figure. 20G presents the EDS spectra of the beads to have an elemental analysis 
of the dried beads. It has been reported [89] that the dried beads of calcium Alg have a 
round, tight, and soft surface, whilstthe Alg-Bru beads present an irregular shape and 
rough surface with considerable wrinkles. Angadi et al [132] claimed that quick drying 
processes as well as heterogeneous structures were mainly responsible for irregular 
shapes of Alg composite dried beads. Higher magnification images demonstrated the 
accumulation of Bru plate-like crystals with various dimensions in the Alg matrix. 
Furthermore, the elemental analysis of the dried beads from EDS showed the presence of 
Ca, P, Na, C, and O. The calcium content relates to both calcium Alg and Bru, while the 
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phosphorous content can be attributed only to the Bru. In addition, Na is also detected 
due to presence of small amount of residual sodium Alg. 
 
 
 
Figure 20. SEM micrographs of Alg 1.5 at magnifications of (A) 50x, (B) 500x and Alg 2-P 0.2 sample 
at magnifications of  (C) 75x, (D) 200x, (E) 1000, and (F) 3000x. (G) EDS spectra of Alg 2-P 0.2 
C 
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3.3.2 Dynamic mechanical analysis (DMA) 
Figure. 21A, 21B, Figure. 22 and table. 4 present DMA results of different 
composite and reference samples versus frequency. As can be seen, the loss factor Q-1 < 1 
in all samples is indicating that all the hydrogel samples presented a solid like behavior. 
Besides, as the concentration of Alg increased, the storage modulus showed an upward 
trend (Figure. 22). An approximate of 35 kPa enhancement in the storage modulus of 
composite samples seemed to be considerable when the concentration of Alg increased 
from 1% to 2%. This improvement can be attributed to the fact that an increase in the 
concentration of Alg led to a denser polymeric chain. In addition, higher crosslinking 
density resulting from an increase in the electrostatic attraction between carboxylate 
groups of Alg and calcium ions can explain this improvement [133]. The comparison 
between the Alg 1.5 and Alg 1.5-P 0.1 samples, which were composed of equal Alg 
concentration, revealed more than 20 kPa improvement in the storage modulus. This 
relates to the fact that Bru component has higher mechanical properties than Alg and the 
polymeric chains movements are restricted by the crystalline component.  
The impact of Bru content on the storage modulus at different frequency can be 
seen in the Figure. 21 and Figure. 22. Obviously, storage modulus at different frequency, 
i.e. 10 and 85 Hz, was significantly enhanced by an increase in the content of Bru. 
However, this improvement was followed by a remarkable decrease when higher content 
of Bru (Alg 2-P 0.4) was introduced into the sample. This can be explained by the fact 
that the higher amount of PO4
3- in the Alg 2-P 0.4 sample is acting as a barrier in the 
crosslinking process. As a result, the sample Alg 2-P 0.4 is less crosslinked than the other 
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two as evidenced by storage modulus results. As can be seen in Figure. 21B, that increase 
in the content of Bru led to reduction in the mobility of polymeric chain and subsequently 
decrease the loss factor (increase in solid like status). 
 
 
  
Figure 21. Effect of the content of Alg (A) and Bru (B) on the storage modulus and loss factor at 
different 
A 
B 
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Figure 22. Effect of changes in the Bru content and Alg concentration on the storage modulus at 10 
Hz 
3.3.3 Swelling ratio 
The release behavior of Alg and its composites is highly dependent upon the 
swelling ratio and swelling kinetics. In fact, the main release mechanism is based on the 
swelling behavior. As we can see in the Figure. 23, the presence of Bru had a favorable 
effect on the swelling behavior of the hydrogel so that at the same concentration of Alg, 
the swelling ratio decreased from 12.72 to 10.29. On the other hand, the swelling 
behaviors of samples were significantly influenced by variation of Alg concentration. The 
swelling ratio showed an upward trend as the concentration of Alg increased and the 
relative content of Bru crystals decreased. We can see that the swelling ratio grew from 7 
to 10.29 with a 0.5% increase in the concentration of Alg. This was followed by 1.09 
further growth in the sample prepared with 2% of Alg.  In addition, the sample Alg 1- P 
0.1 had the lowest swelling ratio because in-situ formed Bru crystals restricted the Alg 
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polymer chain movement, thus hindering penetration of water into the network. Besides, 
as the content of Bru increased in the Alg matrix due to an increase in the primary 
concentration of (NH4)2HPO4, a slight decrease was detected in swelling ratio of Alg 2-P 
0.2 and Alg 2-P 0.4 samples. 
 
Figure 23. Effect of changes in the Bru content and Alg concentration on the swelling ratio 
Figure. 24 shows the swelling kinetics of different samples in PBS media at 37˚C. 
As can be seen, the swelling ratio of the samples increased significantly through swelling 
time passage to reach their maximum ratio. Then, it followed a sharp downward trend 
with further swelling time passage and even ALg-1.5 and Alg 1- P 0.1 samples 
experienced disintegration. Osmotic pressure is the core cause of water penetration into 
the polymeric network and consequently weight gain of the samples [134]. Since the 
strength of –COO -…+ Ca + …-OOC interactions were at its minimum in the swelling ratio 
peak due to the polymer chain expansion, the bonds were easily broken by PO4
3- in the 
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surrounding PBS media. This resulted in disintegration of the Alg and leading to a burst 
release of the drug. 
The significant impact of Bru is considerable in the kinetics of swelling so that the 
composite samples smoothly gain weight and the disintegration process prolonged 
further. This can be attribute to Bru crystals resistance against penetration of the PO4
3- 
functional group and consequently postponing the breakage of –COO -…+ Ca + …-OOC 
interactions. 
 
 
Figure 24. Variation of swelling ratio vs. time in Alg and Alg-Bru composites 
3.3.4 Release behavior 
 Encapsulation efficiency 
The encapsulation efficiencies of the different samples are listed in Table. 6. 
Although we expected that incorporation of Bru into Alg matrix would increase the 
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encapsulation efficiency via retarding the drug leakage as a result of formation of a 
denser surface, the results were unexpected. This can be attributed to the fact that the 
presence of Bru has limited the sol-gel transition and made a delay in crosslinking 
process. This can also be down in part to the time consuming process of the composite 
formation and the leakage of the drug from surface pores. Therefore, more Ibu molecules 
leaked out from the composite samples during fabrication process. Besides, dissolving 
higher amount of drug in the initial polymeric solution resulted in composite beads 
carrying higher amount of drug. Noteworthy that the significant decreased in EE% does 
not seem to be ignorable. 
Table 6. Compositions of loaded hydrogel beads and their encapsulation efficiency (EE) 
Item Sample Sodium 
alginate 
(wt %) 
[(NH4)2HPO4 
(M) 
Ca(NO3).4H2O 
(M) 
Ibuprofen 
(%) 
EE (%) 
1 Alg 1.5-1 1.5 --- 0.2 1 74.97±6.67 
2 Alg 1- P 0.1-1 1 0.1 0.2 1 70.02±5.43 
3 Alg 1.5- P 
0.1-1 
1.5 0.1 0.2 1 73.65±16.14 
4 Alg 2- P 0.1-1 2 0.1 0.2 1 74.96 ± 2.81 
5 Alg 2-P 0.2-1 2 0.2 0.2 1 79.91 ± 2.13 
6 Alg 2-P 0.4-1 2 0.4 0.2 1 63.80 ± 2.23 
7 Alg 2-P 0.2-
1.5 
2 0.2 0.2 1.5 67.68 ± 1.15 
8 Alg 2-P 0.2-2 2 --- 0.2 2 63.24 ± 3.29 
 
 Cumulative release 
As it is evident in Figure. 25, all the formulations demonstrated pH sensitive 
release behavior. It has been reported that pKa of Alg is almost 3.2 and the 
transformation of carboxylate group in the Alg chain into -COOH occurs at a pH lower 
68 
 
than 3 [135]. Therefore, this transformation established hydrogen bonding between –
COOH and hydroxyl group in Alg which restricted the dried beads to swell in simulated 
gastric fluid. The impact of Alg concentration on cumulative release is illustrated in 
Figure. 25A. As we can see, the rate of release is not significant owing to low swelling 
ratio of the samples in acidic condition and all the sample release almost the same level 
of Ibu. Hence, these results suggest that the Ibu was released from the samples by 
diffusion mechanism. Also, low solubility of Ibu in acidic media (simulated gastric fluid) 
could be another reason for slow release of Ibu from the samples. As discussed before, 
the formation of Bru within Alg matrix resulted in loading acidic form of Ibu with –
COOH carboxyl group into carriers. Therefore, formation of hydrogen bonds between –
COOH of Ibu and -COOH of alg is another cause for slow release of Ibu from the carriers 
in acidic environment. This phenomena was also reported for Diclofenac release from a 
hydrogel based on methacrylated Alg [135]. On the other hand, samples in simulated 
intestine fluid (pH=7.4) exhibit a completely different behavior. All the samples showed 
a burst release of Ibu owing to extensive swelling in PBS 7.4 and consequently 
penetration of PO4
3- into the polymer. Besides, all the –COOH groups in Alg and Ibu 
transformed into -COO-  at pH 7.4 which not only increased the solubility of Ibu but also, 
caused electrostatic repulsion between –COO- groups and led to faster release of Ibu.   
 We can see that more than 85% of IBU was released from Ca-Alg samples after 4 
hours in PBS 7.4 while, the Alg 2- P 0.1-1 sample release 62% of entrapped Ibu at the 
same time and further 4 hours was needed to release 81% of entrapped Ibu. Also, we can 
see that the presence of Bru in the Alg matrix resulted in more than 10% decrease in final 
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Ibu release in the Alg 1.5- P 0.1-1 sample. This suggested the positive effect of Bru on 
release behavior and controlled release of Ibu. Although the sample Alg1– P 0.1-1 had 
the highest relative content of Bru, the Ibu release behavior was almost similar to that of 
Ca-Alg. This behavior can be explained by the irregular shape of this sample. Unlike the 
other samples which had the spherical shape, Alg1-P0.1-1 shape tended to be less 
spherical due to platelet-like morphology of Bru. In other words, the beads of Alg1-P0.1-
1 were less stable than the other composite samples. Hence, the disintegration process 
accelerated and a higher content of the drug was released. 
Next step was evaluating the impact of Bru content on release behavior. 
Therefore, Alg2-P0.1-1 was chosen as the reference sample because it had the best 
release profile as well as the beads had sufficient stability so that the beads would remain 
stable following the increase in the content of (NH4)2HPO4. As plotted in Figure. 25B the 
cumulative release decreased when the primary concentration of (NH4)2HPO4 was 0.2 M. 
The Bru crystals resisted against swelling and following PO4
3- penetration. Further 
increase in the concentration of (NH4)2HPO4 had a negative impact on the release profile 
since the beads were less crosslinked than the other two samples and were unable to 
restrict release of Ibu. Furthermore, Figure. 25C demonstrates how initial drug content 
would change the release profile. It is clear that the Alg 2- P 0.2-1.5 sample follows 
almost the same pattern of release as Alg 2- P 0.2-1 sample when the incorporated drug 
increased up to 0.5%. Further increase in the content of drug possibly had reverse effect 
on the release profile owing to intermolecular interactions between sodium Ibu and 
sodium Alg, sodium Ibu and Bru. As a result, less stable beads were formed in a way that 
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the beads exhibit less resistance against release of Ibu to the surrounding media. Hence, 
these results indicate that an increasing in the initial drug content not only decreased the 
EE%, but also it had a reverse effect on release profile. 
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Figure 25. Effects of variations in (A) Alg concentration, (B) Bru content and (C) initial Ibu 
concentration on the release profile of Ibu from Alg and Alg-Bru composite beads at pH 1.5 PBS 
(first two hours) followed by pH 7.4 PBS 
3.4 Conclusion 
The current study was carried out to evaluate in-situ synthetized Alg-Bru as a new 
potentially reinforced carrier for delivering drug and other active biomolecules. To this 
aim, Ibu was actively loaded in the carriers during crosslinking and formation of Bru 
within Alg matrices. According to FT-IR and XRD results, the composite materials were 
successfully fabricated and the drug was loaded into the carriers. SEM images 
demonstrated the significant impact of Bru crystals on the morphology of the beads. In 
addition, the restriction of Alg chain movement by uniformly dispersed Bru crystals was 
the main cause of regulating swelling behavior and enhancing the mechanical behavior. 
Furthermore, improving the swelling behavior ultimately triggered the gradual release in 
composite samples and avoided burst release observed in calcium Alg beads. The 
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optimized formulation prolonged Ibu release for a period of 10 hours. These results seem 
to suggest that the in-situ synthetization of Bru within Alg sufficiently modified release 
behavior. However, the entrapment efficiency was not remarkably improved in 
comparison with that of calcium Alg. The simplicity and effectiveness of the method 
used in the present study to fabricate a pH sensitive DDS can be further improved to 
encapsulate bioactive molecules including other drugs, proteins, vitamins. 
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CHAPTER 4 : Controlled Gentamicin release by Brushite cement modified with 
Alginate 
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4.1 Introduction 
The reconstruction of bone defects, due to trauma and disease, by bone grafting 
represents an important challenge owing to the fact that millions of people are annually 
dealing with it [136]. The gold standard in this respect is defined as autologous bone 
grafting which contains living cells and osteogenic growth factors in order to help the 
formation of new bone tissue. Limited bone sources, associated donor site pain and 
morbidity, possible cell and damaging during transplantation are listed as the main draw 
backs, which have limited autologous bone grafting so far [137-139]. Hence, there is a 
significant demand for synthetic materials which not only can overcome the above-
mentioned disadvantages, but can also help the restoration of bone defects. 
Calcium phosphate bone cements (CPC) and their modified formulations have 
been widely used for treating bone defects since the first time that Brown and Chow 
introduced them in 1980s [140]. Notable biocompatibility, bioactivity, and 
osteoconductivity, as well as similarity to the mineral component of bone, have made 
these materials a proper candidate for treating low or none load-bearing bone defects 
[141-143]. CPC are obtained via a chemical setting reaction between a solid and a liquid 
phase leading to the precipitation of Ca-salts in the form of apatite, hydroxyapatite, 
calcium-deficient hydroxyapatite and Bru [144]. The main advantage of Bru cements 
over apatite ones seems to be having up to two times higher solubility rate in 
physiological conditions [145]. Bru cements are formed as the result of an exothermic 
reaction between an acidic calcium phosphate (i.e. MCPM) and a basic calcium 
phosphate (i.e. β-TCP) according to the following reaction [91]: 
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β-Ca3(PO4)2 + Ca(H2PO4)2.H2O + 7H2O                                   4CaHPO4.2H2O 
Several biopolymers including chondroitin sulfate [146], chitosan [147], gelatin 
[148], and Alg [149] have been incorporated in the cement as additives (less than 1 wt%) 
to modify CPC mechanical and anti-washout properties. Such biopolymers have a high 
potential to entrap biological active agents like stem cells [150, 151] and drug [152] for 
long term treatment of bone regeneration. Among them, Alg seems to be a suitable 
material, as an additive or carrier, to modify cement owing to its biocompatibility, 
biodegradability, and low price [153]. It has been reported that Alg can form Alg gel 
through a crosslinking reaction with release of calcium from CPC and protects the 
cement from primary disintegration on early contact with human body fluids [149].       
Bone regeneration processes are often associated with complications such as 
bacterial infections, and inflammatory responses of the immune system. Thus, 
administration of different drugs, via intravenous injection or oral uptake, has been 
proposed to treat these complications. However, these administration routes may damage 
the non-targeted tissue. Moreover, the efficacy of treatment could be low due to 
insufficient bio-distribution and uncontrolled drug release [154, 155]. On the other hand, 
the intrinsic micro/submicro porous structure of Bru [156] cements has made them a 
highly interesting carrier for delivering of active therapeutic agents such as drugs [157], 
antioxidant [158], and stem cells [150, 151]. The local administration of Gen20 is highly 
recommended for the treatment of bacterial infections owing to its antibacterial activity 
                                                 
20 Gentamicin sulfate 
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against a wide range of microorganisms such as Pseudomonas aeruginosa, 
Staphylococcus aureus, Proteus species, and Enterobacteriaceae [159]. 
4.2 Materials and methods 
4.2.1 Materials 
Sodium alginate from brown algae, β-tricalcium phosphate (β-TCP), 
monocalcium phosphate monohydrate (MCPM), sodium citrate tribasic dihydrate, 
gentamicin sulfate, Dulbecco Modified Eagle’s Medium (DMEM), fetal bovine serum 
(FBS), phosphate buffered saline (PBS), isopropanol, paraformaldehyde, glutaraldehyde 
and [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) were 
obtained from Sigma-Aldrich. Human osteoblast cell line was obtained from the National 
Cell Bank of Iran (NCBI), Pasteur Institute of Iran. In addition, 96-well microtiter plates 
for cell culture were supplied by Nunc, Denmark. All reagents were used without any 
purification.   
4.2.2 Cement preparation 
Bru cement was prepared at room temperature through mixing equimolar amounts 
of β-TCP and MCP powders, solid phase, and distilled water, liquid phase, with the 
powder to liquid (P/L) ratio of 3. In addition, sodium citrate tribasic dihydrate with a 
concentration of 0.5 M was incorporated into the liquid phase as cement retardant agent. 
Predefined amounts of Alg, as listed in Table. 7, were added to the powder mixture in 
order to form the Bru-Alg composite cement. The resulting paste was poured into 
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cylindrical plastic molds for setting. The obtained samples were used for mechanical, 
biological and release experiments.     
4.2.3 Mechanical tests 
The mechanical behavior of Bru and Bru-Alg cements were examined using a 
universal testing machine (Zwick/Roell Z10) with a 10 KN load cell. For the standard 
compressive analysis, cylindrical samples having a diameter of 9 mm and a height of 18 
mm were positioned vertically on a plate supported with a spherical joint to correct the 
non-planar imperfections of the cylindrical base samples. The tests were performed in 
displacement control at a rate of 1 mm/min, according to the ASTM standard F451. The 
same cylindrical geometry, having a diameter of 9 mm and a height of 5 mm, was used to 
perform diametrical tensile test, Brazilian tests, (DTS). For these tests the samples were 
positioned horizontally on the same tilt plate used for the compressive analysis and were 
compressed at a rate of 1 mm/min. 
4.2.4 In-vitro biological assays 
 In-vitro cell culture 
The in vitro characterization was carried out using human osteoblast cell line from 
femoral bone according to the published protocol [160]. The cells were cultured in 
DMEM supplemented with 10% FBS (v/v), 100 U/ml penicillin and 100 μg/ml 
streptomycin followed by incubating them at 37 ˚C in humidified atmosphere containing 
5% CO2.  
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 Cement extraction 
The rates of proliferation and differentiation were calculated using extracted 
samples based on ISO 10993–5 protocol where 0.1 gr of different cement formulations 
were soaked into 1 ml of culture media. After 3, 7 and 14 days, the mediums were 
gathered to be used in different cellular tests. Pure culture medium, maintained under 
similar conditions, was used as the negative control. 
 Cell proliferation 
The proliferation rates of the cells over various cement samples were determined 
by dimethylthiazol diphenyl tetrazolium bromide (MTT) assay. Briefly, 1×104 cells/well 
with 100 μL culture mediums were cultured into 96- well microtiter plates (Nunc, 
Denmark). After 24 hours, the culture medium in each well was withdrawn and replaced 
by 90 µl cement extraction solutions (3, 7, and 14 days) and 10 µl FBS. The medium was 
removed after 24 hours and then 100 µl of MTT solution (0.5mg/ml) was added into each 
well and incubated for 4 hours at 37˚C. In order to dissolve the formed formazan crystals, 
100 μL of isopropanol was added to each well. The plate was placed in a shaker at 37 ˚C 
for 15-20 minutes to dissolve the purple crystals. Finally, the optical density of formazan 
was recorded at 545 nm using a multiwall microplate reader (STAT FAX 2100, USA). In 
addition, the results were normalized respect to the negative control sample (tissue 
culture Polystyrene (TPS)). 
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 Alkaline phosphatase activity (ALP) 
ALP enzyme activity, as an osteoblast cell marker, was measured to evaluate cell 
activity. In order to determined ALP activity the cells were trypsinized after reaching to 
appropriate concentration (5-7 days). About 5000 cells in 1000 μl of culture medium 
containing 10% FBS were poured into each well of sterile 6-well culture plates and the 
cements at the concentration of 30 μg/ml were exposed to the cells. After 7 and 14 days 
of culturing, cell supernatant (medium on the samples) was removed and examined by 
auto-analyzer (Hitachi Model 911, Germany, AUDIT Kit). The results were normalized 
similarly to those of MTT assay. 
 Alizarin red staining 
Evaluation of calcific deposition by osteoblastic cells was carried out by 
conducting alizarin red staining assay. This was done by culturing 5000 cells in a 6-well 
plate followed by adding the sample at the concentration of 30 μg/ml to each well. The 
medium was withdrawn after 10 days and cells rinsed twice with NaCl solution (0.9%). 
Then, cells were fixed by paraformaldehyde (1%) for 20 minutes and then they were 
stained using Alizarin red solution (2%) at pH 4.2 and room temperature for 45 minutes. 
Finally, cells were washed with NaCl solution prior to taking images by optical 
microscopy. 
 Cell attachment and morphology 
Cell adhesion assay was carried out in order to investigate the morphology and 
adhesion of isolated cells to the cement surface. Fist the sterilized samples were placed 
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into each well of 24-wells plate. Then, 4000 -5000 cells in 50 μL of culture medium were 
dropped on each sample surface and were placed in an incubator for 24 hours.  
Afterwards, the samples were washed four times with DMEM to remove unattached cells 
from the surface. Then, glutaraldehyde 2.5 % (v/v) was used to fix the cells at room 
temperature followed by rinsing them with graded alcohol of 50, 60, 70,80,90,95 and 100 
%, respectively. Finally, adhesion of the cells to the sample was detected by secondary 
electron microscopy (SEM -TescanVegaï, Czech) at an accelerating voltage of 30 KV    
4.2.5 Gentamicin loading  
Gen was loaded only onto most promising samples, selected after compression 
and in vitro characterizations. Predetermined amounts of Gen, as reported in Table. 8, 
were incorporated in the liquid phase (Gen Solution, GL) or in the solid phase (Gen 
Powder, GS) in order to study the effect of Gen incorporation protocol on the release 
behavior.  
  Characterization 
Setting time measurements were conducted according to ASTM C 191-04a for 
hydraulic cements using a Vicat needle with the diameter of 1mm equipped with a 300 gr 
plunger. Periodic penetration of Vicat needle was performed after molding the cements 
paste into cylindrical shape having a diameter of 9 mm and height of 5 mm. The final 
setting time refers to the time when the Vicat needle penetrates less than 1 mm. 4 
different positions in each sample were checked in terms of penetration depth to ensure 
that the cements were fully set and the test was repeated three times. 
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In order to characterize the main functional groups of the composite materials, 
FTIR was used. Samples in the form of powders were mixed with KBr and then pressed 
to prepare KBr disks. Spectra were collected in the range 400 - 4000 cm-1 using a 
Nicolet 380 Fourier transform infrared spectrometer (Thermo Fisher scientific Inc, USA). 
The crystalline structure of different samples was examined using PANalytical 
Empyrean x-ray diffractometer operating with CuKα over the brag 2Ɵ range of 5-55˚. 
The resulting diffractograms were compared with ICDD (JCPDS) standards number 9-
0077 for Bru. In addition, the crystalline size was measured following Scherrer's equation 
[161]: 
t=kλ/BCosƟ 
where k assumed to be 0.9 and λ is the wavelength of X-Ray radiation, B represents full 
width at half maximum, and Ɵ is the brag angle. 
A TG-DTA Netzsch Gerätebau STA 409 was used to carry out thermogravimetric 
analysis (TGA) along with differential thermal analysis (DTA). The thermal analysis was 
carried out in the range of 40-700 ˚C in nitrogen atmosphere with a heating rate of 10 
K.min-1. In addition, morphological and microstructural investigations were carried out 
using JEOL SEM at an accelerating voltage of 10 KV. 
4.2.6 Soaking properties in phosphate buffer saline  
Cement behaviors in in-vitro conditions like (37 °C, PBS buffer) in terms of 
degradation, mechanical properties, chemical and structural stability are of vital 
importance. To this regard, 4 different samples namely Alg-Bru, Bru-Alg-GL 1, Alg-Bru-
GL 2, and Alg-Bru-GL 5, having a diameter of 9 mm and height of 3 mm, were 
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immersed into 10 ml of PBS at 37 ˚C for predefined time intervals. At each time interval, 
samples were withdrawn from PBS solution and placed at 37 °C to completely dry. Then, 
the samples were subject to DTS to obtain strength of the samples after different soaking 
times. Finally, chemical stability and microstructure of fractured surface were examined 
by FTIR spectroscopy and SEM (Hitachi S-2500), respectively.  
4.2.7 Drug release 
Release of Gen from different cement formulations was evaluated at 37 ˚C in PBS 
at pH 7.4. Drug release was measured by placing ≈0.4 gr of different cement 
formulations in the form of disk in 10 ml of PBS. 5 ml of released medium for each 
sample was withdrawn at predefined period of time and replaced with 5 ml of fresh PBS. 
The content of Gen in each withdrawn medium aliquot was spectrophotometrically 
determined via a calibration curve on a UV-visible spectrophotometer (AGILENT-Cary 
100, USA) at 248 nm. The related calibration curve equation was A=0.0866C, R2 = 0.96, 
where A represents adsorption at 248 nm and C indicates the concentration of Gen and 
Gen fractional release percentage was calculated as follows:  
% Fractional Release =Rt/R0*100 
where Rt is Gen release at time interval t and R0 is the initial amount of Gen 
loaded on the cements. In order to determine R0, an amount (≈0.4 gr) of each cement 
formulation was crushed into powders and then, immersed in 10 ml of PBS. The media 
were kept in the incubator at 37 ˚C for one week and subjected to rigorous shaking for 5 
minutes followed by sonication for 30 minutes every day to ensure that all the Gen 
loaded on the cements was release. This step was followed by centrifuging the media at 
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3000 rpm for 5 minutes and the final determination of Gen concentration was carried out 
using UV visible spectrophotometer. The release for each formulation was measured in 
triplicate and the results were normalized respect to the weight of each sample. 
4.2.8 Data analysis 
The results presented as mean value and standard deviation of at least three 
repeats. In addition, one-way ANOVA with LSD post hoc test using SPSS (version 16.0 
SPSS Inc. Chicago IL) was employed to analyze the data where probability value p<0.05 
were defined as statistically significant. 
4.3 Results and discussion 
4.3.1 Compressive strength 
Variation of compressive strength and elastic modulus of different cement 
formulations versus Alg percentage are reported in Table. 7. As we can see, both of these 
parameters followed a similar pattern in which they increased to a maximum value as 
0.5% (w/w) of Alg added into Bru cement. Although the mechanical properties declined 
when Alg concentration further increased to 1%, these samples still possess higher 
mechanical properties in comparison to pure Bru cement. The compressive strength, as 
well as elastic modulu,s sharply decreased with another 1% increase in the content of 
alginate. It was reported that [149] Alg in the Bru cement acted like a water reducing 
agent which enhanced cement consistency, increasing mechanical properties through 
formation of a tighter packing. The decline in the mechanical properties as the 
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concentration exceed from 0.5% likely arose from agglomeration of Alg component as 
well as hindrance effect of Alg on Ca and P ions diffusion.  
 Mechanical properties of bone cements are highly dependent on the type of 
cement as well as fabrication technic. Therefore, the reported values in this criteria is 
different in each study. For instance, Fullana et al [152] reported that the compressive 
strength of calcium phosphate cement continuously decreased from 5.78 MPa to 2.4 
MPa, as up to 6 wt% of pectin was added to the cement. Almost Similar results was 
obtained by Zhao et al [150] which Alg microspheres were incorporated into calcium 
phosphate cement. On the other hand, some studies reported compressive strength higher 
than 20 MPa for the same type of calcium phosphate cements [149, 162]. The 
compressive results of the cement fabricated in the present study exceeded the minimum 
level reported before. 
Table 7. Mechanical properties of cements respect to Alg variations 
Item Name Alginate content (wt %) Elastic modulus (MPa) Compressive strength (MPa) 
1 Bru 0 783.62 ± 124.27 9.43 ± 1.49 
2 Bru-Alg 0.5 0.5 1507.17 ± 267.74 10.36 ± 1.89 
3 Bru-Alg 1 1 912.02 ± 109.41 9.8 ± 0.84 
4 Bru-Alg 2 2 438.48 ± 115.21 9.05 ± 0.8 
 
4.3.2 In-vitro biological assays 
 Cell proliferation 
Figure. 26A presents the viability of human osteoblast cells exposed to different 
cement extractions obtained after 3, 7 and 14 days. The results indicate that the 
proliferation rate of all the cement formulations were almost in the same level of control 
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group and Bru-Alg 1 cement supported higher proliferation rate (p* < 0.1) than control 
and other cements within the considered time intervals. Moreover, a slight increase in 
proliferation rate, respect to pure Bru cement, was observed. Therefore, the results 
evidenced no negative effects of cements extraction on the cell viability.  
 ALP activity 
One of the conventional markers for determinating the osteoblastic phenotype 
expression is ALP [163]. Figure. 26B represents the relative activity of ALP for the 
cements with different concentration of Alg over the time period of two weeks. The 
results indicated that ALP activity after 7 days for all the cement was almost of the same 
level of control sample, and cement with 1% of Alg promoted higher ALP activity 
(p*<0.1). In addition, further increase in culture time resulted in increase in the ALP 
activity for all the formulations, so that all the formulations promoted higher ALP activity 
respect to control samples. Besides, for both time intervals the cement with 1% Alg (Bru-
Alg 1) possessed the highest ALP activity, which is quite in a good agreement with MTT 
assays, where this formulation had the highest cell viability for all of the time intervals. 
The primary mechanical properties results, along with cell proliferation and ALP 
outcomes, suggest that the cement with 1 % Alg (Bru-Alg 1) seems to be the best cement 
to carry Gen. So, hereafter further experiments, including alizarin red and cell adhesion 
assays, along with loading Gen and related tests were conducted on the Bru-Alg 1 
cement, referred as Bru-Alg. 
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Figure 26. A) Viability of osteoblast cells on various cements after 3, 7 and 14 days. B) ALP activity 
of various cements after7 and 14 days. C -F) Optical microscopy images after alizarin red staining 
for control sample at 100×(C), 300× (D); and Bru-Alg cement at 100×(E), 300× (F). 
 
 Alizarin Red staining 
The calcium mineralization capacity of osteoblast cells exposed to the extracts of 
Bru-Alg and control samples are shown by Figure. 26C-F. A significant difference 
between the cement and control sample is quite observable.  The results indicated clear 
positive staining and deposition of calcium by cells seeded on Bru-Alg. This can be 
attribute to the presence of calcium phosphate materials which progress the bone 
mineralization. Besides, ion exchange capability of Alg component possibly has a 
positive impact on the biomineralization process. 
C D E F 
A B 
87 
 
 Cell attachment and Morphology 
Figure. 27 shows SEM micrograph of Bru-Alg cement seeded with osteoblast 
cells. It was found that the osteoblast cells are capable of attaching and proliferating on 
the surface of Bru-Alg cement. This result indicates that the surface of cement composite 
is osteoconductive and provides a suitable platform for the growth and the proliferation 
of osteoblast cells. Moreover, the osteoblast cells attached to the cement with a normal 
morphology which is flattened (Figure. 27 A and B). In addition, the cells were able to 
penetrating in the cement through the pores of Bru-Alg . (Figure. 27 C and D).  
 
Figure 27. SEM micrograph of osteoblast cells seeded on Bru-Alg cement. 
4.3.3 Characterization 
 Setting time 
One drawback of Bru cements is represented by the rapid setting time, which was 
reported to be 150 s [162], therefore sodium citrate tribasic monohydrate, in the 
concentration of 0.5 was introduced to the liquid phase as a setting retarding agent. This 
was based on the fact that citrate ions interacted with β-TCP component to restrict β-TCP 
dissolution and consequently postponed precipitation of Bru crystals [164]. In addition, 
P/L ratio is another important parameter for prolonging setting reaction so that lower P/L 
A B C D 
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would result in a slower setting reaction. The P/L ≈ 3 was proposed as the best ratio for 
Bru cement [162]. The final setting times of the different cement formulations are listed 
in Table. 8. As we can see, the retarding agent significantly increased the setting time of 
Bru, which is in a good agreement with a previous study [165]. Besides, incorporation of 
Alg in the solid phase yielded in a longer setting time which is due to the inhibition effect 
of Alg on Bru forming reaction, as reported by Chen et al [166]. Moreover, it was 
reported [167] that incorporation of Alg would cause a chemical reaction between Alg 
and the cement which possibly results in the Alg gelation, according to the below 
reaction, and in the postponed precipitation of Bru cement: 
 2C5H7O4COONa + Ca
2+                                      (C5H7O4COO)2Ca + 2Na
+ 
Furthermore, it was demonstrated that [168] sulfate ions, arising from Gen, 
prolonged the setting of Bru crystals at least at low Gen percentage contents. This was 
also observed for our samples, so that the cement with 5% Gen in liquid phase was set 
after 38 minutes. However, the comparison between Nr-Bru-Alg-GL 5 and Bru-Alg-GL 5 
revealed that sodium citrate was the main responsible for prolonging the setting time. 
Moreover, the results showed that incorporation of Gen in solid phase led to longer 
setting time than in liquid phase, except for Bru-Alg-GS 2, which had the highest Gen 
concentration considering P/L=3. This could be due to the formation of calcium sulfate 
dehydrated crystals, which acted as the nucleation sites for Bru formation [168]. 
Table 8. different formulation of loaded cements and their setting time 
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Item Name Alginate 
Concentration (wt 
%) 
Gentamicin 
concentration (wt 
%) 
Na3C6H5O7 (M) Setting Time 
(min) 
1 Bru 0 0 0.5 19.1±1.0 
2 Bru-Alg  1 0 0.5 22.5±1.1 
3 Bru-GL 2 0 2 0.5 22.3±0.9 
4 Bru-Alg-GL* 1 1 1 0.5 24.3±0.8 
5 Bru-Alg-GL 2 1 2 0.5 25.8±1.2 
6 Bru-Alg-GL 5 1 5 0.5 37.5.1±1.2 
6 Nr**-Bru-Alg-GL 5 1 5 0 3.3±0.4 
8 Bru-GS*** 2 1 2 0.5 28.8±0.6 
9 Bru-Alg-GS 1 1 1 0.5 31.3±0.9 
10 Bru-Alg-GS 2 1 1 0.5 34.1±1.0 
*Gen dissolved in liquid phase, ** no retardant was used, *** Gen powder incorporated in solid 
phase 
 FTIR 
Figure. 28A presents FTIR spectra of Gen loaded cements Alg-bru-GS 2 and Alg-
bru-GL 5 which were compared to the spectra of reference materials such as Alg-Bru and 
Gen. The spectra of the composite materials showed features typical of the main 
components, as  the two doublet O-H stretching bands detected in the high frequency 
region (3116, 3288, 3489, and 3539 cm-1) due to two crystallization water molecules of 
Bru [100], whose corresponding H-O-H bending mode appeared at 1641 cm-1 [101]. The 
bands observed at 1134, 1061, and 985 cm-1 are due to P-O stretching mode of 
phosphate group [100, 169]. In addition, the corresponding peaks of P-O-H stretching 
mode and P-OH bending mode were detected at 1209 and 876 cm-1 [101]. The bands in 
the low frequency region, namely at 525, 577 and 661 cm-1, were arising from P-O 
deformation mode of phosphate group [169]. The spectra of Bru-Alg and pure Bru were 
almost identical. This was indeed due to overlapping the characteristics peaks of Alg in 
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the 1000-1200 cm-1 region [99] with those of phosphate group. Besides, the 
concentration of Alg in Bru matrix was negligible. The weak bands due to the Gen sulfate 
molecule can be better evidenced in the subtraction spectra [Bru-Alg-GL 5] – [Bru-Alg] 
and [Bru-Alg-GS 2] – [Bru-Alg] (Figure. 28B). Two broad bands centred at 3400 and 
above 3000 cm-1 are assigned to OH and NH stretching modes of the alcohol and amine 
groups in Gen, partially overlapped with band due to OH stretching modes of the 
adsorbed water vapor. The band at 1510 cm-1 is related to N-H bending mode. The 
sulfate group is characterized by a strong and complex absorption in the region 1100-
1000 cm-1 together with a sharp band at 619 cm-1 which corresponds to vibrational 
bending mode of S-O [170, 171]. The complexity of the former absorption is due to the 
superimposition of sulfate absorption with CO/CC/CN stretching modes, too. Amine salts 
should give rise to multiple broad IR absorption in the region 2700-2300 cm-1 due to 
combination bands, which can also be detected in our spectra, suggesting that at least a 
fraction of Gen is present as cationic salt in the final cement formulation [172]. It is 
noteworthy that some shifts were observed specially at high frequency regions in loaded 
sample suggesting some specific interaction of Gem with such a complex matrix. The 
overall intensity of the bands was enhanced in the case of the sample prepared with the 
drug dissolved into liquid phase. This effect pointed out a better loading outcome for this 
preparation method (Figure. 28B).  
3.3.3. XRD 
Figure. 28C presents the XRD spectra of Bru, Bru-Alg, Gen, Bru-Alg-GS 2, and 
Bru-Alg-GL 5 which were compared to Bru standard JCPDS card (09-0077). The XRD 
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results confirmed the formation of Bru cement in all formulations. In addition, some 
residual β-TCP was observed in the unloaded cement formulation. The XRD spectra did 
not remarkably change as a result of Gen incorporation, except for the disappearance of 
β-TCP peak at 2Ɵ = 26.7. The main difference between Gen loaded cement spectra and 
the reference one is the increased relative intensity of several peaks within the 2Ɵ range 
of 30-50 in the case of solid incorporation. Moreover, it has been reported [168] that 
loading Gen into CPC may lead to the formation of gypsum (CaSO4.2H2O). Yet, it is not 
possible to assure that this compound was formed within the cement due to similar 
crystallographic structure between gypsum and Bru.  
The mean crystalline size of loaded and unloaded cements was calculated using 
the diffraction pattern of (020), (021), (041), (-221), and (220) crystalline planes. The 
results showed that the calculated mean crystalline size for Bru, Bru-Alg, Bru-Alg-GL 5, 
Bru-Alg-GS 2 were 92.4 ± 29.2, 107.1 ± 35.8, 92.4 ± 30.8, and 61.2 ± 36.6 nm, 
respectively. As we can see incorporation of Alg yielded to increase the crystalline size 
of the cement while, addition of Gen decreased the crystalline size so that the smallest 
one belonged to Bru-Alg-GS 2 which had the highest content of Gen. 
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Figure 28. A) FTIR spectra of loaded cements along with the reference materials B) FT IR 
Subtraction spectra of loaded cements in comparison with spectrum of pure solid Gen. C) XRD 
spectra of loaded cements and the reference materials. 
 Thermal analysis 
Thermal behavior and stability of loaded and unloaded cement were evaluated by 
TGA, DTG, and DTA. A continuous weight loss was observed within the range of 50-
650 ˚C for both loaded and unloaded cements, which were 24% and 23.5 %, respectively 
(Figure. 29A). The difference between the two curves is not significant and the main 
weight loss corresponds to transformation of Bru into monetite (90-140 ˚C, 16%) and 
monetite into calcium pyrophosphate (280-420 ˚C, 5.5%) [127, 128]. Therefore, the 
impact of Gen addition on the TGA results is not significant. As we can see in the Figure. 
29B, the DTA results indicated two and three endothermic peaks for unloaded and loaded 
cements respectively. The first endothermic peaks related to dehydration of Bru and 
formation of monetite at 116 ˚C for both samples. The second endothermic peak for Bru-
C 
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Alg cements appeared at 310°C, which was due to calcium pyrophosphate formation. The 
Gen loaded cement possesses two small endothermic peaks at 312 and 401 ˚C, 
corresponding to transformation of monetite and melting of Gen respectively. Figure. 
29C presents the DTG spectra of Alg-Bru, and Gen as reference materials and Gen 
loaded cement. It is observable that the range of 70-170°C is the main region in which 
both cements mainly lost their weight. The similarity between the DTG results of loaded 
cement with that of unloaded one suggests that similar decomposition steps occurred in 
both of them. Yet, it is logic to state that loaded cement presented more stable crystalline 
structure due to slight shift to a higher temperature in the obtained DTA and DTG 
spectra. 
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Figure 29. A)TG, B)DTA, and C)DTG spectra of Gen, Bru-Alg, and Bru-Alg-GL 5 
 Morphology study 
Fracture surface of Bru and Bru-Alg cements after compression test were used to 
take SEM images and conduct microstructure study. As shown in Figure. 30A, 30B, and 
30C Bru cements had a heterogeneous structure composed of large plate and fine needle 
like crystals which were accumulated in multilayers. Similar results were obtained in a 
B 
C 
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previous work conducted by Cama et al. with the same fabrication technique [165]. In 
contrast, incorporation of Alg into the cement led to formation of petal like crystals along 
with fine plate like structures (Figure. 30D, 30E, and 30F). 
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Figure 30. SEM images taken from fracture surface of A-C) Bru and E-F) Bru-Alg at the 
magnification of 2000, 5000, and 10000 
4.3.4 Soaking in phosphate buffer saline  
Figure. 31A shows the FTIR spectra of Bru-Alg-GL 5, recorded to investigate 
chemical changes following soaking in PBS. The obtained spectra contained all the 
characteristics peaks of Bru after different time intervals and no significant difference 
was observed in the typical bands of Bru matrix. The results indicated the chemical 
stability of the cements within the soaking time. The DTS results, after soaking the 
samples in PBS, are reported in Figure. 31B. As we can see incorporation of Gen resulted 
in DTS improvement which is related to decrease in crystalline size of Bru as stated by 
Bohner et al [168] and observed in XRD results. The results indicated that in all samples 
an increase in DTS, within the soaking time of 1 to 7 days, was followed by a sharp 
decrease for the remaining time of immersion. For instance, the primary strength of 1.66 
MPa for Bru-ALg-GL 2 increased to 1.81 MPa within 7 days of soaking in PBS. This can 
be attributed to crystal growth, as evidenced by SEM, and further hardening of Bru by 
allowing setting reaction to continue. Therefore, the small pores were reduced and an 
interlocked crystal structure was achieved [165, 173, 174]. Then, 0.27 and 0.61 Mpa 
declines in DTS were noticeable after 14 and 30 days, respectively. Dissolution of Bru, as 
well as leaching of Alg and Gen, were the main reasons for the observed diminish in DTS 
results [166].  
Figure. 31C-F illustrates the SEM images taken from fracture surface of the Bru-
Alg-GL 5 cement after 1 and 30 days of in-vitro soaking. The comparison between 
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samples with different aging time revealed that heterogeneous crystals after one day 
(Figure. 31C and 31D) of soaking transformed to homogeneous plate like crystals at the 
end of 30 days. In addition, the results indicated that Bru crystal grew as a result of in-
vitro soaking so that an increase was observable in the Bru crystals dimensions (Figure. 
31E and 31F). 
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Figure 31. A) FTIR spectra of Bru-Alg-GL 2 cement different soaking time B) 9 Diametrical tensile 
strength (DTS) results of different cements after various soaking time in PBS C-F) SEM micrographs 
taken from fracture surface of Bru-Alg-GL 5 after 1 day at 500× (C) , 2000× (D) and 30 days at 500× 
(E) and 2000× (F) 
4.3.5 Drug release 
The in-vitro Gen release by the Bru cement was evaluated compared to: addition 
of Alg, content of drug, method of drug incorporation. The error bars are not presented in 
the figures to avoid overlapping: the obtained standard deviation of triplicate repeat was 
lower than 5%. Figure. 32A shows the Gen release profile from different cement 
formulation when the drug was dissolved in the liquid phase in the preparation step. The 
release profile can be summarized into three phases: primary release, secondary release, 
and plateau level over 14 days. The primary burst release falls into the range of 37.9 ± 2.2 
to 58.5± 3.4% after 24 h for Bru-Alg-1GL and Bru-Alg-2GL, respectively. This 
significant initial increase in the released drug level was related to the part of drug that 
was physically entrapped by the cement. In addition, high solubility of Gen in PBS is 
another significant reason for the primary burst release [175]. Correspondingly, the band 
corresponding to the vibrational bending mode of S-O at 619 cm-1 almost disappeared 
E F 
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after 24 hours of incubation in PBS as shown by Figure. 31A confirming the initial burst 
of Gen after 24 h. This was followed by the secondary burst release with lower rate from 
24h to 144h and it was noticeable that an increase in the initial concentration of Gen 
resulted in a greater drug release within this period of time. The third phase started after 
one week of release experiment where all the release profile almost followed a period of 
stability. The results indicated that Bru cement released almost 91.5% ± 4.9 % of the 
loaded Gen after 2 weeks, while Bru-Alg with similar concentration of drug reached to 
the level of 86.5 ± 4.5 % and further decrease to less than 80% of fractional released was 
observed in Bru-Alg-GL 1. The results revealed that addition of Alg had a positive effect 
on the release profile especially in the first and second phase of release, this can be due to 
selective interaction of Gen with mannuronic residues of Alg [176]. Singh et al [177] 
stated that Gen is a cationic drug with a positive net charge in physiological conditions 
which stablishes electrostatic interaction with COO- of Alg mannuronic blocks. Since 
Alg was incorporated at a low concentration (1%), the cement with the lowest 
concentration of drug had the strongest electrostatic interactions. Similar release profiles 
were obtained when Gen was incorporated into solid phase of the cement. Yet, for all the 
cement formulations, Gen release profiles showed an increase in the fractional release so 
that almost all of the loaded drug was released in PBS (Figure. 32B). This can be attribute 
to a less uniform distribution of drug and consequently a lowered interaction with the 
cement materials. Furthermore, addition of Alg to the cement negatively influenced the 
release profile in the way that the lowest release rate achieved in Bru-2GenS with 93.6 ± 
3.9 %.  
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Figure 32. Cumulative Gen release by different cement formulations as Gen A) dissolved in liquid 
phase and B) incorporated in solid phase 
 
4.4 Conclusion 
The present study focused on functionalizing Bru cement through incorporation of 
Alg in order to improve mechanical and biological characteristics as well as to control 
A 
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Gen release from this bone cement. The primary results indicated that adding 1 wt% Alg 
to the solid phase of cement improved both mechanical and biological performance. In 
addition, the cement is a viable platform for cells to attach with a normal morphology and 
penetrate inside the cement structure. Using Gen in the form of solution during the 
cement preparation step yielded to a more efficient drug loading than using Gen in form 
of powder. Moreover, addition of Gen to the Bru-Alg cement enhanced crystalline 
stability and mechanical properties as shown by thermal analysis and diametrical tensile 
test. Although both Gen and Alg prolonged the setting time, the retarding agent played 
the major role in extending setting time. The soaking experiment in PBS medium 
revealed that the cements chemically and mechanically remained almost stable during 
soaking time. Finally, Alg component exhibit a positive effect on the release behavior 
when Gen was dissolved in liquid phase at low concentrations so that more than 10% 
decrease was observed in the fractional release. These results indicate the positive effect 
of Alg on Bru cement mechanical, biological, structural and antibiotic release behaviors. 
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CHAPTER 5 : Conclusion  
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The first part of the present thesis discus about in-situ synthetization of Alginate-
brushite hydrogel composite. Initial pH of solutions and primary concentration of 
phosphate precursors were chosen as the variables to obtain the optimum conditions and 
the following results were obtained: 
 Alginate-brushite hydrogel composites were obtained through an in-situ process 
 The brushite crystals started forming at initial pH value of 6 
 The interaction between brushite crystals and alginate matrix was weak  
 The increase in the initial concentration of phosphate precursor resulted in more 
crystalline structure 
 Samples prepared at pH value of 8 had the most stable crystalline structure 
 Brushite crystals promoted the biocompatibility of alginate   
In the second part, the release of ibuprofen from the hydrogel composite 
fabricated in the first part was taken into consideration. The impact of brushite on the 
morphology, mechanical properties and swelling behavior along with drug-carrier 
interaction were deeply investigated. The bellow outcomes were concluded from this 
part: 
 Ibuprofen was loaded on the in-situ synthetized alginate-brushite hydrogel beads. 
 Transformation of Na-ibuprofen to its acidic form occurred within the loading 
procedure. 
 The brushite within alginate matrix improved mechanical properties 
 The brushite crystals restricted swelling behavior of alginate  
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 Less crosslinked beads obtained as the concentration of (NH4)2HPO4 reached to 
0.4M.  
 The hydrogel composite beads released ibuprofen in a controlled manner. 
The final part was aimed to improve mechanical properties of brushite cement and 
modify gentamicin sulfate release from brushite cement by adding alginate to the 
matrix. Following outcomes were obtained at the end of this part: 
 Addition of Alginate up to 1% improved mechanical and biological 
performance of the cement. 
 Morphology of brushite changed from plate and needle like to petal like as 
Alginate was added to the cement. 
 Alginate, gentamicin sulfate, and sodium citrate tribasic remarkably 
prolonged the setting time. 
 Dissolving gentamicin sulfate in the liquid phase yielded to better loading 
conditions. 
 The cement present adequate mechanical and chemical stability during 
soaking time 
 Adding alginate significantly improved release profile of gentamicin 
sulfate when gentamicin sulfate was dissolved in liquid phase at low 
concentration  
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